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SUMMARY
Studies of peritoneal dialysis kinetics have focused on fluid 
and solute exchange between the peritoneal microcirculation and the 
hypertonic dialysis solution instilled into the peritoneal cavity. 
The intraperitoneal fluid, however, is also absorbed continuously by 
convective flow into the peritoneal cavity lymphatics. Thus, 
measured net ultrafiltration at the end of each exchange (drain 
volume minus infusion volume) represents the difference between total 
net transcapillary fluid transport into and lymphatic drainage out of 
the peritoneal cavity during the dwell time.
Lymphatic absorption from the peritoneal cavity occurs mainly 
via stomata on the undersurface of the diaphragm and exceeds 50 
ml/hour in patients with ascites unless the subdiaphragmatic or 
mediastinal lymphatics are obstructed by tumour or fibrosis. 
Lymphatic absorption in the iatrogenic "ascites" of peritoneal
dialysis may also be significant and thus merits investigation.
The role of lymphatic absorption during peritoneal dialysis was 
evaluated in a rat model and in adults and children on continuous 
ambulatory peritoneal dialysis (CAPD). Lymphatic absorption was
calculated from the rate of removal of albumin added to the infused 
dialysis solution, and net transcapillary ultrafiltration was 
estimated from the dilution of the initial dialysate albumin
concentration.
Intraperitoneal volume and lymphatic absorption were determined 
serially during six hour exchanges in rats using 15% dextrose
25
dialysis solution. The net transcapillary ultrafiltration rate 
decreased exponentially to zero after 330 minutes, whereas lymphatic 
absorption proceeded at an almost linear rate throughout the 
exchanges, averaging 4.7 ± 0.9 (SEM) ml/hour. Peak ultrafiltration 
volume was observed before osmolar equilibrium between serum and 
dialysate was reached and occurred when the net transcapillary 
ultrafiltration rate had decreased to equal the lymphatic absorption 
rate. Thereafter, the net fluid absorption rate represented 
lymphatic absorption in excess of concurrent net transcapillary 
ultrafiltration. Measured net ultrafiltration at the end of the 
exchanges averaged 24 ± 2 ml and represented only 46 ± 5% of total
net transcapillary ultrafiltration during the dwell time.
Standardised four hour exchanges using 2 litres of 2.5% dextrose 
dialysis solution were performed in 18 adult CAPD patients. 
Cumulative lymphatic absorption averaged 343 ± 39 ml and reduced
potential net ultrafiltration at the end of the exchanges by 56 ± 6%. 
Extrapolated to four x six hour exchanges per day, lymphatic 
absorption reduced potential daily net ultrafiltration by 82 ± 9%, 
daily drain volumes by 18 ± 2%, daily urea clearances by 14 ± 1% and
daily creatinine clearances by 13 ± 1%. These findings indicate that 
net ultrafiltration and solute clearances are reduced significantly 
by lymphatic absorption in all CAPD patients.
Eight of the patients had transperitoneal solute transport 
rates indicative of high peritoneal permeability x area. Absolute 
lymphatic absorption did not differ between patients with average and 
high peritoneal permeability x area, but caused a proportionately
26
greater reduction in net ultrafiltration in patients with high 
peritoneal permeability x area (p < 0.005) since these patients had
more rapid glucose absorption from the dialysate (p < 0.001) and 
lower cumulative net transcapillary ultrafiltration (p < 0.05). 
Patients with high peritoneal permeability x area had daily net fluid 
absorption from the dialysis solution even though daily net 
transcapillary ultrafiltration averaged 2.1 ± 0.A litres. Failure of 
peritoneal ultrafiltration in CAPD, in the absence of a dialysate 
leak, occurs when daily lymphatic absorption exceeds daily net 
transcapillary ultrafiltration.
Four hour exchanges using A0 ml/Kg of 2.5% dextrose dialysis 
solution were performed in six children on peritoneal dialysis. 
Cumulative lymphatic absorption averaged 10.A ± 1.6 ml/Kg and
reduced total net transcapillary ultrafiltration by 73 ± 10%.
Extrapolated to four x six hour exchanges per day, lymphatic 
absorption reduced potential daily drain volumes by 27 ± 5%, daily 
urea clearances by 2A ± A% and daily creatinine clearances by 22 ± 
5%. The infusion volumes of dialysis solution, corrected for body 
surface area, were similar in children and adults. Net ultra­
filtration, scaled for body surface area, was lower in children than 
in adults with average peritoneal permeability x area (p < 0.05) due
to a combination of relatively higher lymphatic absorption and lower 
net transcapillary ultrafiltration. Thus, lymphatic absorption 
caused a proportionately greater reduction in net ultrafiltration and 
solute clearances in children than in adults.
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Intraperitoneal glucose and insulin absorption were evaluated 
during two hour exchanges using 15 ml of 2.5% dextrose dialysis 
solution in diabetic rats with and without peritonitis. Greater than 
50% of insulin absorption in both groups was via the lymphatics. 
Dialysate insulin and glucose were absorbed more rapidly during 
exchanges in the rats with peritonitis (p < 0.05). However, the 
relative absorption rates of insulin and glucose and the 
hypoglycaemic response to absorbed insulin were similar in the two 
groups. These data suggest that intraperitoneal insulin requirements 
in diabetic CAPD patients are not increased during peritonitis 
provided that the dialysate glucose load and oral carbohydrate intake 
remain unchanged.
Intraperitoneal cholinergic drugs constrict the subdiaphragmatic 
stomata and so may decrease lymphatic drainage. Two hour exchanges 
were performed in ambulant rats using 20 ml of 2.5% dextrose dialysis 
solution with and without the addition of the anticholinesterase 
agent, neostigmine. Net ultrafiltration (p < 0.01) and solute
clearances (p < 0.05) were enhanced in the neostigmine group by a 
reduction in lymphatic absorption (p < 0.01) and without an increase 
in transperitoneal transport of water and solutes into the peritoneal 
cavity. These results indicate that the efficiency of peritoneal 
dialysis can be increased when lymphatic absorption is reduced.
Phosphatidylcholine is a normal component of fluid within the 
serous cavities and is removed in the dialysate effluent during CAPD. 
Four hour exchanges were performed in ambulant rats using 20 ml of 
A.25% dextrose dialysis solution with and without added
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phosphatidylcholine. Net ultrafiltration (p < 0.05) and solute
clearances (p < 0.05) were enhanced after the exchanges with
phosphatidylcholine due to a reduction in lymphatic absorption 
(p < 0.01). Transperitoneal transport of water and solutes did not
differ between the treated and control rats. Phosphatidylcholine may 
have clinical application in alleviating poor ultrafiltration after 
long-dwell peritoneal dialysis exchanges.
These studies emphasise the important contribution of lymphatic 
absorption to loss of ultrafiltration and solute clearances after 
long-dwell peritoneal dialysis exchanges. Thus, reappraisal of 
current understanding of peritoneal dialysis kinetics is required to 
incorporate the role of lymphatics. Pharmacological reduction of 
lymphatic absorption may provide an alternative means of improving 
the efficiency of peritoneal dialysis without altering 
transperitoneal transport of water and solutes into the peritoneal 
cavity.
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PART I REVIEW AND RATIONALE
Chapter 1, ANATOMY AND PHYSIOLOGY OF PERITONEAL DIALYSIS
1.1 HISTORICAL PERSPECTIVE
The clinical potential of using the peritoneal membrane as a 
dialysing membrane was recognised over sixty years ago (1,2). Long­
term intermittent peritoneal dialysis, however, did not become a 
viable alternative to haemodialysis until a permanent indwelling 
peritoneal catheter was developed in 1964 by Palmer and colleagues 
(3) and later modified by Tenckhoff (4). Nevertheless, due to 
inadequate dialysis and repeated episodes of peritonitis, the 
cumulative technique survival of intermittent peritoneal dialysis was 
relatively low (5) and haemodialysis remained the predominant 
dialysis therapy.
The concept of portable/wearable equilibrium peritoneal 
dialysis, using several long-dwell exchanges each day, was introduced 
by Popovich and Moncrief in 1976 (6) and heralded a new era for
peritoneal dialysis. Clinical studies demonstrated that adequate 
steady state control of uraemia, sodium and water balance, acidosis 
and hyperkalaemia could be achieved in patients with end-stage renal 
failure using four or five exchanges per day, and the technique was 
renamed Continuous Ambulatory Peritoneal Dialysis (CAPD) (7). 
Oreopoulos replaced the use of glass bottles containing dialysis 
solution with a polyvinylchloride bag which could be rolled up when 
empty and carried under the clothing without being disconnected from 
the transfer set (8). After equilibrating for the selected dwell
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time, the dialysate was drained into the polyvinylchloride bag and 
the connection-disconnection procedure repeated using an aseptic 
technique. This development markedly reduced the peritonitis rate 
and, apart from modifications in the design of the administration set 
and peritoneal catheter, this basic CAPD system remains unchanged 
today.
The number of patients on peritoneal dialysis has increased 
annually during the past decade (9,10) and CAPD now has an 
established role in renal replacement therapy (11). At the end of 
1986 more than 30,000 patients were on peritoneal dialysis therapy 
worldwide and in some countries, including the United Kingdom, more 
than half of all patients beginning dialysis are now started on CAPD 
(12).
1.2 THE PERITONEAL DIALYSIS SYSTEM
During peritoneal dialysis fluid and solutes exchange across the 
peritoneal membrane between the peritoneal microcirculation and 
hypertonic solutions infused into the peritoneal cavity.
THE PERITONEUM
The peritoneum is a continuous membrane which covers the inner 
surface of the abdominal wall, invests the visceral organs and forms 
the mesentery that connects loops of bowel. The total surface area
of the peritoneum approximates the patient's body surface area
(13,14). The inner surface of both the parietal and visceral
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peritoneum is lined by a monolayer of flattened cells with numerous 
microvilli (mesothelium), supported by its basement membrane and the 
interstitium (15,16). The blood vessels and lymphatics within the 
peritoneal interstitium are interspersed between extracellular fluid 
and a gel-like matrix containing collagen and elastin fibres, 
fibroblasts and fat (15,16). The morphology of peritoneum from 
normal and non-dialysed uraemic patients is similar, but after 
beginning peritoneal dialysis alterations in peritoneal 
ultrastructure are often observed (15-17). The mesothelial layer may 
exhibit absence of the microvilli, widening of the intercellular 
junctions or even loss of mesothelial cells, whereas the interstitium 
may become thickened due to submesothelial fibrosis and stromal 
oedema. These changes in peritoneal morphology tend to be more 
pronounced in patients with previous episodes of peritonitis (15-17).
PERITONEAL BLOOD FLOW
The absolute peritoneal blood flow rate in man is not known but 
gas diffusion studies suggest that the effective blood flow rate is 
at least 70 ml/min (18). The peritoneal capillaries are located 
mainly in the deeper layers of the interstitium and are usually 
greater than 20 pm from the mesothelial surface (17). Under basal 
conditions only 20% of the peritoneal capillaries are perfused and 
perfused capillaries may underlie less than 0.5% of the total 
peritoneal surface area (19).
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DIALYSATE FLOW RATE
The peritoneal cavity normally contains only a small volume of 
isosmotic fluid (less than 100 ml), yet most adult patients can 
tolerate rapid instillation of at least 2 litres of dialysis solution 
without abdominal discomfort. The dialysate flow rate can be 
adjusted by changing the infusion volume or total cycle time. In 
intermittent peritoneal dialysis dialysate flow rates of 40 ml/min 
are achieved by rapid cycling while in CAPD flow rates usually
average 7 ml/min.
THE DIALYSING MEMBRANE
Solutes and fluid may transfer across the peritoneal membrane by 
intercellular, vesicular or transcytoplasmic pathways. At least six
major anatomical resistance sites to transperitoneal transport have 
been identified (20): the fluid films within the capillary lumen, the 
endothelium, the endothelial basement membrane, the interstitium, 
the mesothelium and the fluid films and stagnant pools of dialysis 
solution within the peritoneal cavity. The permeability of the 
peritoneal membrane is related inversely to the sum of these
resistances and the area of the peritoneum effectively involved in
solute and fluid transport is always much lower than total peritoneal 
surface area because of perfusion : dialysate flow mismatching.
Thus the peritoneum in peritoneal dialysis may be regarded as a 
composite, reusable, biological, dialysing membrane which is almost 
continuously exposed to non-physiological dialysis solutions.
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1.3 KINETICS OF PERITONEAL DIALYSIS
In peritoneal dialysis net removal of water and sodium is 
dependent on the net ultrafiltration volume at the end of the 
exchange and the net removal of solutes is determined by the solute 
mass transfer rate. The net ultrafiltration volume is equal to the 
drain volume minus the infusion volume of dialysis solution, assuming 
that the intraperitoneal residual volume remains constant. The mass 
transfer rate of each solute is calculated as:
(Vt x Ct) - (VQ x CQ)
.....................    equation 1.
t
where VQ and V^. = infusion volume and drain volume, respectively 
CQ and Ct = solute concentration in the infusion and drain 
volume 
t = total cycle time
The solute clearance rate is calculated by dividing the solute 
mass transfer rate by the mean serum solute concentration. Solute 
clearances in peritoneal dialysis are determined primarily by the 
lowest of the effective peritoneal blood flow rate, peritoneal 
permeability x effective membrane transfer area for the solute and 
the dialysate flow rate (18). The relatively low efficiency of 
peritoneal dialysis is compensated for in CAPD by dialysis being 
performed almost continuously (20).
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Ultrafiltration and solute mass transfer in peritoneal dialysis 
are dependent on:
a) the dwell time, osmolality and volume of exchanges.
b) interindividual and intraindividual variation in the dialysing 
membrane.
1.3.1 ULTRAFILTRATION
DWELL TIME OF DIALYSIS SOLUTION
In peritoneal dialysis ultrafiltration is induced by osmotic 
pressure, and the transperitoneal osmotic pressure gradient is 
generated primarily by the glucose concentration of the dialysis 
solution (21). The water flux rate across the peritoneum (Jw) is 
equal to the product of hydraulic permeability (Lp), effective 
membrane area (A), and the sum of osmotic ( A tt) and hydrostatic (AP) 
transmembrane pressure gradients. That is:
Jw = Lp A (Att + AP)  equation 2.
Consequently the net transcapillary ultrafiltration rate (Jw) is 
maximum at the beginning of the exchange and decreases exponentially 
as the transmembrane glucose concentration gradient is dissipated by 
a combination of transperitoneal glucose absorption and dilution of 
the dialysis solution by the ultrafiltrate. The intraperitoneal 
volume increases until a maximum is reached at or near crystalloid 
osmolar equilibrium (22). Thereafter, the dialysis solution remains
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isosmotic with serum and net absorption of fluid proceeds almost
linearly at an average rate of 40 ml per hour (23-26).
OSMOLALITY OF DIALYSIS SOLUTION
For any given patient the net transcapillary ultrafiltration
rate (Jw) correlates linearly with the glucose concentration of the 
dialysis solution and the transperitoneal osmotic gradient (27).
Thus increases in the osmolality of the dialysis solution result in a 
higher initial transcapillary ultrafiltration rate, an increase in 
the peak intraperitoneal volume, prolongation of the dwell time until 
peak ultrafiltration and osmolar equilibrium are observed, and delay 
until net fluid absorption begins (28,29). After peak ultra­
filtration the rate of intraperitoneal fluid absorption is similar, 
irrespective of the tonicity of the infused dialysis solution 
(25,26,28). However, the absorbed glucose load also increases 
proportionately with higher initial dialysate glucose concentrations 
(27,30). The absorbed glucose makes a significant contribution to 
total daily calorie intake and promotes anabolism by stimulating 
endogenous insulin secretion (30), but has the disadvantage of 
predisposing patients to obesity and hyperlipidaemia (31). Despite 
active interest in alternative, less absorbable osmotic agents, 
glucose remains the only agent used in current commercial dialysis 
solutions (28,32).
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VOLUME OF DIALYSIS SOLUTION
In exchanges using dialysis solutions of equal initial glucose 
concentration, drainage volumes are proportional to the instillation 
volume (23,33). Although the initial net transcapillary
ultrafiltration rate is unaltered, the increased dialysate glucose 
load with higher infusion volumes augments the peak ultrafiltration 
volume and prolongs the dwell time until osmolar equilibrium is 
reached (23,28). Nevertheless the clinical application of instilled 
volumes of dialysis solution greater than 2.5 litres is limited by 
patient tolerance and by the increased risk of complications related 
to raised intra-abdominal pressure (34-36).
INTERINDIVIDUAL VARIATION IN ULTRAFILTRATION
CAPD patients exhibit a wide interindividual variation in net 
ultrafiltration even if the dwell time, osmolality and volume of 
exchanges are standardised (37-39). Transcapillary ultrafiltration 
during exchanges using the same dialysis solution is primarily 
dependent on interpatient differences in peritoneal permeability x 
area (equation 2). Transperitoneal osmotic pressure is equal to the 
sum of the products of the osmolar gradient and the peritoneal 
reflection coefficient of each solute. Therefore high peritoneal 
permeability x area reduces cumulative net transcapillary 
ultrafiltration by two related mechanisms:
a) rapid absorption of glucose from the dialysate dissipates the
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transperitoneal osmotic gradient more quickly during the dwell 
time.
b) at any given glucose concentration gradient the lower peritoneal 
reflection coefficient for glucose generates reduced osmotic 
pressure (Air) and decreases water flux (Jw).
Representative differences in ultrafiltration kinetics between 
patients with normal and high peritoneal permeability x area are 
depicted in Figure 1.
INTRAINDIVIDUAL VARIATION IN ULTRAFILTRATION
Irreversible loss of peritoneal ultrafiltration capacity in 
peritoneal dialysis patients has been observed most frequently in 
Europe (40-42) and usually results from a persistent increase in 
peritoneal permeability x area (Type I membrane failure). Although 
an aetiological role is as yet unproven, alterations in the 
mesothelial layer (43) and the use of dialysis solutions containing 
acetate (41,42) have both been associated with increased peritoneal 
permeability x area. Similar but temporary changes in peritoneal 
morphology and physiology occur during episodes of peritonitis 
(43,44). However, peritoneal ultrafiltration capacity in stable 
CAPD patients (37,45) and in patients with ultrafiltration failure 
(41) appears to be unrelated to the number of prior episodes of 
peritonitis.
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Figure 1: Representative intraperitoneal fluid volumes during 
exchanges using 2 litres of 2.5% dextrose dialysis
solution in CAPD patients with average and high
transperitoneal absorption of glucose from the dialysate.
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1.3.2% SOLUTE MASS TRANSFER
DWELL TIME OF DIALYSIS SOLUTION
In peritoneal dialysis the rate of equilibration of dialysate 
solutes with plasma depends on the solute molecular weight, 
configuration and charge (46). Thus in most patients small molecular 
weight solutes, such as urea, almost completely equilibrate with the 
plasma within six hours (dialysate/plasma concentration ratios 
approach unity) whereas large solutes continue to equilibrate at an 
almost linear rate until the end of the dwell time.
Solutes diffuse across the peritoneum in a direction to 
discharge their concentration gradients. Other than glucose, ionised 
calcium and buffer anion, the direction of solute movement is from 
the peritoneal microcirculation to the dialysis solution. The 
diffusive mass transfer of solutes (Js) is equal to the product of
membrane permeability (Ps), effective peritoneal surface area (A),
and solute concentration gradient (AC). That is:
Jg = Ps A AC .....equation 3.
The concentration gradient for diffusion is maximum near 
completion of infusion of the dialysis solution and for small solutes 
decreases exponentially until equilibrium with extracellular fluid is 
approached.
Solute transport across the peritoneal membrane also occurs 
with ultrafiltration due to solvent drag. The peritoneum offers
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greater resistance to accompanying solutes than to water so that the 
concentration of solutes in the ultrafiltrate is less than in plasma 
water (solute sieving). Hence convective solute transport (Js) is 
the product of water flux (Jw)> sieving coefficient of the 
peritoneal membrane (S) and mean serum solute concentration (Cs). 
That is:
Jg = Jw S CS   equation 4.
Consequently the contribution of convective transport to solute 
mass transfer diminishes as water flux decreases during the dwell 
time. Thus the dialysate sodium concentration initially decreases 
due to solute sieving with ultrafiltration and increases later in the 
dwell time due to diffusion (47). For this reason hypernatraemia may 
result if excessive ultrafiltration is sustained by consecutive, 
short-dwell hypertonic exchanges. Solute sieving also leads to 
osmolar equilibrium being reached before glucose equilibrium.
Convective and diffusive solute transport are interrelated. 
Ultrafiltration enhances diffusive mass transfer of solutes other 
than glucose, ionised calcium and buffer anion by maintaining the 
concentration gradient with solute sieving. In contrast diffusion 
limits ultrafiltration because of glucose absorption.
Since the dialysate concentration of urea approaches equilibrium 
with plasma after six hours dwell time, net removal of urea in CAPD 
is determined primarily by the dialysate drain volume (dialysate flow 
rate) (18). In contrast mass transfer of large solutes, such as
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proteins, is influenced predominantly by the patient's peritoneal 
permeability x area. If the exchange dwell time is reduced below 
four hours, small solute mass transfer is also influenced by 
peritoneal permeability x area. The effective membrane area (A) for 
each solute is unknown and so peritoneal permeability x area have to 
be considered together in studies of peritoneal transport (48).
OSMOLALITY OF DIALYSIS SOLUTION
The rate of equilibration of small solutes with plasma is only 
marginally reduced with hypertonic solutions despite solute sieving 
with ultrafiltration (25,46). Accordingly dialysate/plasma solute 
ratios show a minor decrease during the initial hours of hypertonic 
exchanges. Hyperosmolar glucose and buffer anion dialysis solution 
have an additive vasodilator effect on the peritoneal 
microcirculation (49). Increased peritoneal permeability x area is
observed both during and after exchanges using hypertonic glucose
solutions (50,51) and will tend to counteract the delay in solute
equilibration induced by the concurrent increase in hypotonic
ultrafiltrate. Consequently in most patients urea approaches 
equilibrium after six hours during hypertonic exchanges and small 
solute mass transfer will depend predominantly on the dialysate 
drain volume.
Adverse effects of hypertonic exchanges on peritoneal transport 
of solutes other than glucose are relatively minor. Protein losses 
in the dialysate are unrelated to the daily ultrafiltration volume 
(33,52) and, in the absence of peritonitis, for a given patient
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remain almost constant each day (53,54). A small net mass transfer 
of calcium from the dialysate during 1.5% hydrated dextrose exchanges 
is usually reversed during 4.25% exchanges due to the increased 
ultrafiltration volume (55).
VOLUME OF DIALYSIS SOLUTION
The rate of equilibration of dialysate solutes with their plasma 
concentration is slowed during exchanges using higher volumes of 
dialysis solution (33,56). The delay in solute equilibration during 
exchanges with higher instilled volumes is most likely secondary to 
reduced peritoneal surface area/dialysate volume relationships since 
indices of peritoneal permeability (solute dialysance ratios and 
protein losses) are unchanged (33,56). With long-dwell exchanges 
small solutes approach equilibration with plasma, and solute mass 
transfer is again dependent mainly on the drain volume.
INTERINDIVIDUAL VARIATION IN SOLUTE TRANSPORT
Interindividual variation in peritoneal solute transport rates 
can be demonstrated mathematically by calculating the mass transfer 
area coefficient (24,57-59) or clinically by comparing solute 
equilibration rates during standardised exchanges (Figure 2) 
(60,61).
Interpatient differences in solute equilibration rates during 
standardised exchanges are dependent primarily on peritoneal 
permeability x area (equations 3 and 4). In patients with high 
peritoneal permeability x area the mass transfer of small molecular
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(LA) and low (L) peritoneal transport. Reproduced with 
permission of Dr. Z.J. Twardowski, University of Missouri- 
Columbia.
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weight solutes in long-dwell exchanges decreases proportionately with 
the reduction in drain volume (61). Reducing the dwell time in these 
patients captures maximum ultrafiltration while maintaining near 
complete equilibration of small molecular weight solutes and so 
increases net solute removal. Incomplete equilibration of small 
solutes after long-dwell exchanges is observed in patients with 
markedly reduced peritoneal permeability x area. No apparent cause 
for reduced peritoneal transport is evident in the majority of these 
patients (61), although some have systemic vascular disease or 
extensive peritoneal fibrosis (62,63). These patients require high 
dialysate flow rates to achieve adequate daily peritoneal clearance 
rates.
INTRAINDIVIDUAL VARIATION IN SOLUTE TRANSPORT
Significant sequential changes in peritoneal solute mass 
transfer are infrequent in CAPD patients (64-68) and, other than 
during peritonitis episodes, the diffusive mass transfer properties 
of the peritoneum remain relatively constant in most patients (64- 
66). Even if membrane resistances to small solute transport are 
altered (57), dialysate/plasma ratios still approach equilibrium by 
the end of long-dwell exchanges in CAPD. A minority of CAPD patients 
develop reduced peritoneal mass transfer of solutes without 
concomitant loss of ultrafiltration (Type II membrane failure) (60). 
Decreased permeability x area in these patients is often due to 
massive intraperitoneal adhesion formation or sclerosing peritonitis 
and usually necessitates transfer from CAPD (69,70).
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Chapter 2 ANATOMY AND PHYSIOLOGY OF THE PERITONEAL CAVITY LYMPHATICS
2.1 HISTORICAL PERSPECTIVE
Von Recklinghausen in 1863 was the first to propose that carbon 
particles, red blood cells, proteins and fluid move from the 
peritoneal cavity into the diaphragmatic lymphatics via openings in 
the subdiaphragmatic peritoneum, which he called stomata (71). Other 
investigators subsequently claimed that the stomata were artifacts 
(72,73), but the presence of these specialised terminal lymphatics in 
animals and man has since been confirmed by light and electron 
microscopy (74-78). The considerable absorptive capacity of the 
peritoneal cavity lymphatics was recognised by physiologists earlier 
this century (79-82) and has been utilised to perform 
intraperitoneal blood transfusions in the foetus and infant (83,84).
The recent expansion of peritoneal dialysis therapy has 
promoted renewed interest in the morphology of the peritoneum (14-19) 
and the kinetics of transperitoneal ultrafiltration and solute mass 
transfer (20-68). Review of the anatomy and physiology of the 
peritoneal cavity lymphatics indicates that the role of lymphatic 
absorption in the kinetics of peritoneal dialysis also merits 
investigation.
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2.2 ANATOMY OF THE PERITONEAL CAVITY LYMPHATICS
2.2.1 THE LYMPHATIC PATHWAYS
Lymphatic drainage from the peritoneal cavity occurs mainly 
through specialised end lymphatic openings (stomata) located on the 
undersurface of the diaphragm (85-88). Moreover, absorption is 
greatest from the right side overlying the liver (87). Absorption by 
the lymphatic capillaries within the interstitium of the mesentery, 
parietal peritoneum and omentum contributes a minor proportion of 
the total peritoneal lymphatic drainage (88-90).
The lymphatic capillaries coalesce to form a rich plexus of 
collecting lymphatics within the muscular portion of the diaphragm, 
which anastomoses with the lymphatics from the pleural surface. From 
the diaphragmatic lymph nodes, most of the lymphatic trunks travel 
retrosternally with the internal mammary vessels to the anterior 
mediastinal lymph nodes around the thymus and return almost 80% of 
the peritoneal lymphatic drainage to the venous circulation via the 
right lymph duct (89,91). Efferent lymphatics from the anterior 
mediastinal nodes may, however, occasionally drain to the central 
veins on the left side in association with or separate from the 
thoracic duct. Lymphatic drainage from the remainder of the 
peritoneum, including part of the diaphragm, returns to the systemic 
circulation via the thoracic duct (89). Cannulation of the thoracic 
duct during peritoneal dialysis in the rat collected less than 30% of 
the total estimated lymphatic drainage (92).
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The major substernal and other minor lymphatic pathways from the 
peritoneal cavity are summarised in Figure 3.
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Figure 3: Anatomical pathways of lymphatic absorption of 
intraperitoneal fluid.
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2.2.2 THE SUBDIAPHRAGMATIC STOMATA
The lacunae of the end lymphatics in the subdiaphragmatic 
peritoneum are only separated from the peritoneal cavity by 
mesothelium, a loose meshwork of connective tissue and lymphatic 
endothelium (75,76). Transmission and scanning electron microscopy 
show that the stomata permit absorption of intraperitoneal fluid, 
cells, particles and colloids into the underlying lymphatic lacunae 
via extracellular pathways (75,93).
The mesothelial cells that overlie the lymphatic lacunae are 
smaller and separate from each other more readily than the cells in 
the surrounding mesothelium (75,94). The stomata are formed by the 
separation of adjacent mesothelial cells and, in the rat, can 
accommodate spherical particles up to 22.5 pm in diameter (95). The 
submesothelial basement membrane and lattice of connective tissue 
become fenestrated at the stomata (96) and the mesothelial cells 
adjoin the lymphatic endothelial cells to form a channel from the 
peritoneal cavity to the lumen of the underlying lacuna (97,98). 
Actin filaments are abundant in the cytoplasm of the mesothelial and 
endothelial cells around the stomata and may help maintain the 
patency of the stomata during relaxation of the diaphragm (99,100).
2.2.3 MECHANISM OF LYMPHATIC ABSORPTION
The rate of lymphatic absorption from the peritoneal cavity 
depends on the excursions of the diaphragm during respiration (99-
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101). During expiration the diaphragm relaxes, adjacent mesothelial 
and endothelial cells in the roofs of the lacunae separate from each 
other to form open junctions, suction is created by the distension of 
the lacunae and intraperitoneal fluid is absorbed. In inspiration 
the contraction of the diaphragm closes the gaps between the 
overlying mesothelial and endothelial cells and empties the lacunae 
into the efferent lymphatics. Backflow into the peritoneal cavity 
during inspiration is prevented by the overlapping of the endothelial 
cells in the roofs of the lacunae (76), and the valves in the 
efferent lymphatics maintain forward flow induced by lymphatic 
contractility and by changes in intrathoracic pressure (76,101). The 
increased lymphatic absorption rate from the right hemidiaphragm is 
most likely due to compression of the liver against the 
subdiaphragmatic stomata during respiration (94).
2.3 PHYSIOLOGY OF THE PERITONEAL CAVITY LYMPHATICS
2.3.1 FUNCTION
The lymphatics draining the peritoneal cavity act as a one-way 
system, returning excess intraperitoneal fluid and protein to the 
systemic circulation. The sum of hydrostatic and osmotic pressure 
gradients across the peritoneum normally favours a minor net inflow 
of fluid into the peritoneal cavity (28). Bidirectional transfer of 
small solutes occurs by diffusion and by solvent drag. 
Macromolecules (molecular weight greater than 20,000), however,
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exhibit minimal direct reabsorption into the peritoneal capillaries 
(102) and, after unidirectional transport from the peritoneal 
microcirculation, are transported back from the peritoneal cavity to 
the venous circulation by convective flow in the lymphatics. 
Peritoneal lymphatic drainage of serous fluid normally equals its 
rate of formation and only a small volume of isosmotic fluid is 
maintained in the peritoneal cavity.
The lymphatics carrying fluid and solutes from the intestinal 
mucosa traverse the mesentery before draining into the cisterna chyli 
and the thoracic duct but are not significantly involved in 
absorption of isosmotic fluid from the peritoneal cavity per se 
(88,89).
Absorption by the peritoneal cavity lymphatics and phagocytosis 
by resident intraperitoneal macrophages are the major first lines of 
defence after a bacterial inoculum enters the peritoneal cavity 
(103,104). Bacteria have been observed in the thoracic duct lymph of 
dogs within 10 minutes of intraperitoneal injection (105) and have 
been recovered from the mediastinal lymph nodes of patients who have 
died of peritonitis (106). The macrophages in the omentum provide an 
efficient defence against bacteria, but the omental lymphatics only 
play a minor role in absorption of fluid from the peritoneal cavity 
(90).
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2*3*2 ABSORPTIVE CAPACITY OF THE PERITONEAL LYMPHATICS
The lymphatics draining the peritoneal cavity are virtually the 
sole pathway for absorption of intraperitoneal isosmotic fluid, 
biologically inert particles, colloids and cells (89,94,101,107). 
The absorptive capacity of the peritoneal cavity lymphatics can be 
evaluated in normal animals from the rate of uptake of isosmotic 
fluid (plasma, whole blood, crystalloid solutions) instilled into the 
peritoneal cavity (79-82,86-88,108-114). Representative values of 
the considerable lymphatic absorption rates in animals and man are 
shown in Table 1. Obliteration of the subdiaphragmatic peritoneum or 
ligation of the parasternal lymphatic trunks markedly reduces the 
rate of intraperitoneal fluid absorption (88,108).
TABLE 1; RATES OF LYMPHATIC ABSORPTION FROM THE PERITONEAL CAVITY IN 
DIFFERENT SPECIES
SPECIES INFUSION VOLUMES 
(BODY WEIGHT)
INFUSED SOLUTION ABSORPTION RATE REF.
Rat 20 ml (per Kg) Homologous Plasma 6 ml/Kg/hour 108
Rabbit 20 ml (per Kg) Homologous Plasma 3.5 ml/Kg/hour 108
Cat 50 ml (2.4-2.7 Kg) Homologous Serum 4.2-6.0 ml/hour 88
Dog 1000 ml (13-18 Kg) 0.9% Saline 16.8 ml/hour* 109
Man 1000 ml (45-86 Kg) 0.9% Saline 33 ml/hour* 110
* After serum and intraperitoneal fluid reached osmolar 
equilibrium (references 109 and 110).
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2.3.3 FACTORS CONTROLLING LYMPHATIC ABSORPTION
Physiological factors influencing the rate of lymphatic 
absorption include the intraperitoneal fluid volume and pressure, 
posture and the rate and depth of respiration.
Lymphatic and peritoneal transcapillary absorption are both 
increased by raised intraperitoneal hydrostatic pressure (112) and 
decreased after paracentesis (115). Hyperventilation, induced by 
breathing carbon dioxide, increased whereas anaesthesia and phrenic 
neurectomy reduced lymphatic absorption (113,114). Upright posture 
with small intraperitoneal volumes reduces the rate of lymphatic 
flow, although absorption still occurs due to propulsion of 
intraperitoneal fluid towards the diaphragm by intestinal peristalsis 
(108). The circulation of intraperitoneal fluid towards the 
diaphragm also explains the relative frequency of abscess formation 
in the right subphrenic space following entry of bacteria into the 
peritoneal cavity (116). Fowler successfully localised infection in 
the pelvis of patients with diffuse peritonitis by elevating the head 
of their beds by twelve to fifteen inches (117). Although 
obstruction of the subdiaphragmatic stomata by fibrosis or fibrin may 
reduce lymphatic absorption after infectious peritonitis, chemical 
peritonitis induced by sodium hypochlorite increased the rate of 
lymphatic drainage in the recovery period (118). This rise in 
lymphatic absorption may be related to rapid regeneration of end 
lymphatics after injury (119).
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Factors known to influence peritoneal lymphatic drainage are 
summarised in Table 2.
TABLE 2; FACTORS INFLUENCING LYMPHATIC ABSORPTION FROM 
PERITONEAL CAVITY
1. Intraperitoneal fluid volume
2. Intraperitoneal hydrostatic pressure
3. Rate and depth of respiration
4. Posture
5. Intestinal peristalsis
6. Patency of the diaphragmatic and mediastinal lymphatics
THE
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Chapter 3* ROLE OF LYMPHATIC ABSORPTION IN ASCITES
3.1 PATHOPHYSIOLOGY OF ASCITES
The role of peritoneal lymphatic absorption in the pathogenesis 
of ascites is well established (120-123). Ascites does not develop 
until net transperitoneal inflow of fluid into the peritoneal cavity 
exceeds the rate of fluid efflux via the peritoneal cavity 
lymphatics.
Net influx of fluid into the peritoneal cavity may be induced by 
several pathological alterations in transcapillary forces (equation 
2), including:
a) A rise in hepatic sinusoidal and portal hydrostatic pressure
b) A reduction in serum oncotic pressure
c) An increase in peritoneal hydraulic permeability
The rate of peritoneal lymphatic absorption of this inflow of
fluid is influenced by the intraperitoneal fluid volume, 
intraperitoneal pressure and the patency of the lymphatic pathways. 
During accumulation of ascites, the resultant fluid shifts into the 
peritoneal cavity cause a relative reduction in the intravascular 
volume and stimulate sodium and water retention by the kidneys. As 
the ascitic fluid volume increases, the concurrent rise in
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intraperitoneal pressure will reduce transcapillary forces for 
further ascites formation. Accordingly a steady state will be 
reached eventually when the volume of ascites and body weight remain 
constant, and the rate of ascites formation is balanced by its rate 
of absorption.
The continuous bidirectional exchange of fluid in ascites 
precludes estimation of lymphatic drainage directly from the rate of 
absorption of isosmotic fluid. Consequently lymphatic absorption in 
ascites must be calculated indirectly.
3.2 CALCULATION OF LYMPHATIC ABSORPTION IN ASCITES
The peritoneal lymphatic absorption rate in ascites has been 
estimated from the rate of mass transfer of labelled colloids from 
the peritoneal cavity to the systemic circulation. This formulation 
is dependent on the following observations:
a) Intraperitoneal macromolecules of molecular weight greater than 
20,000, such as albumin, are returned to the venous circulation 
almost exclusively by the peritoneal lymphatics (89,102,124, 
125).
b) Isosmotic intraperitoneal fluid is drained by the peritoneal 
lymphatics without change in the concentration of index 
macromolecules (111,112,126-128).
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Thus lymphatic absorption during the time of study (F^) may be 
calculated as:
VD x A cd 
Fl =     equation 5.
Cp
where VD = volume of distribution of the tracer colloid (plasma
volume)
A C D = rise in plasma concentration of the tracer colloid 
Cp = time averaged mean intraperitoneal concentration 
of the marker colloid
The stability of radio-labelled colloids in tissue fluids, the 
adequate mixing of the tracer colloid in the intraperitoneal fluid, 
and the safety and reproducibility of this technique have been 
established (129-131).
3.3 RATES OF LYMPHATIC ABSORPTION IN ASCITES
The mass transfer rates of radio-iodinated serum albumin (128, 
130,131) and other radio-colloids (131-134) from the intraperitoneal 
fluid to the blood have been utilised to compare lymphatic flow rates 
from the peritoneal cavity in patients with hepatic (128,130,131), 
malignant (131-134) and nephrogenic ascites (130).
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3*3*1 HEPATIC ASCITES
Lymphatic drainage in hepatic ascites is increased via two major 
pathways (135-137). Prior to the onset of ascites in hepatic 
cirrhosis, increments in hepatic lymph formation, induced by 
increased intrasinusoidal hydrostatic pressure, are initially matched 
by rises in hepatic regional lymph drainage via the thoracic duct 
(136). After the capacity of hepatic lymph drainage is exceeded, 
interstitial fluid leaks from the surface of the liver into the 
peritoneal cavity. This rise in regional lymphatic absorption in 
hepatic cirrhosis is represented pathologically as an increase in 
both the number and size of the lymphatics draining through the porta 
hepatis (138). The upper limit to hepatic lymphatic drainage via the 
thoracic duct is at least 10 litres per day (122,139). Hepatic 
lymphatic drainage is most likely limited since, although the 
thoracic duct becomes dilated with increasing flow (140), its ostium 
at the junction of the left internal jugular and subclavian veins 
remains fixed in diameter (139). Consequently cannulation or
surgical bypass of the ostium of the thoracic duct increases regional 
lymphatic absorption, reduces fluid overflow into the peritoneal 
cavity and improves ascites (140-142).
Lymphatic absorption from the peritoneal cavity, however, is 
relatively independent of the above pathway, since most of the 
absorbed fluid drains via the right lymph duct rather than the 
thoracic duct. Mediastinal lymphoscintigraphy confirms that the 
substernal lymphatic pathways are the major route for absorption of
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intraperitoneal fluid and macromolecules in hepatic ascites (131, 
132). Estimations of peritoneal lymphatic absorption in 10 patients 
with hepatic ascites ranged from 24 to 223 ml per hour and averaged 
80 ml per hour (128,130,131). The ascitic volume per se probably 
produces the high lymphatic flow rate. The large intraperitoneal 
fluid volume will ensure constant contact of fluid with the 
undersurface of the diaphragm and the concurrent rise in 
intraperitoneal pressure will enhance movement of fluid into the 
diaphragmatic lymphatics. Hepatic ascites has been controlled
successfully by insertion of a peritoneo-venous shunt, which in 
effect further increases lymphatic absorption from the peritoneal 
cavity (143).
3.3.2 MALIGNANT ASCITES
Metastatic invasion of the subdiaphragmatic peritoneum is not 
uncommon in patients with intra-abdominal malignancy (144,145) and 
may at least partially obstruct lymphatic drainage from the
peritoneal cavity (146,147). Subdiaphragmatic lymphatic capillaries 
filled with malignant cells are shown in Figure 4. Mediastinal 
lymphoscintigraphy in patients with malignant ascites often fails to 
demonstrate the patency of the diaphragmatic lymphatics or identify
the mediastinal lymph nodes (131-134). Peritoneal lymphatic 
absorption in 22 patients with malignant ascites ranged from 1 to 63 
ml per hour and averaged only 11 ml per hour (131). Moreover, the 
calculated lymphatic flow rate correlated with the concurrently
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Figure A.a: Autopsy specimen of the diaphragm and subdiaphragmatic
peritoneum from a patient with malignant ascites 
secondary to adenocarcinoma of the body of the 
pancreas. The subdiaphragmatic lymphatic capillaries 
are filled with malignant cells (original 
magnification x AO).
Photomicrograph courtesy of Dr. Mark Hurt, Department 
of Pathology, University of Missouri-Columbia.
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Figure A.b: High power photomicrograph of the subdiaphragmatic
lymphatics of the same patient, showing a 
subdiaphragmatic lymphatic capillary partially 
occluded by malignant cells (original magnification x 
200).
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performed lymphoscintigram (131). Thus, lymphatic absorption in 
malignant ascites may be markedly reduced by tumour invasion of the 
diaphragmatic and/or mediastinal lymphatics.
Likewise patients with schistosomal hepatic fibrosis and ascites 
have significant fibrous thickening of the subdiaphragmatic
peritoneum, which limits flow into the diaphragmatic lymphatics 
(148). Obliteration of the undersurface of the diaphragm with 
fibrous tissue significantly reduces the rate of absorption of 
instilled isosmotic fluid in experimental animals (88, 124) and 
increases the incidence and severity of ascites in animals with
infrahepatic portal hypertension (123). Neither portal hypertension 
or obstruction of the diaphragmatic lymphatics alone induced ascites 
in most of the study animals (123).
3.3.3 NEPHROGENIC ASCITES
Nephrogenic ascites is defined as dialysis associated ascites 
for which no primary cause can be identified (130). Most of the
patients who have developed this form of ascites have been treated
with intermittent haemodialysis and have a preceding history of 
cardiac failure or refractory fluid overload (149). Lymphatic 
absorption rates in 3 of these patients averaged 15 ml per hour, 
which is comparable to results in patients with malignant ascites 
(130). Increased central venous pressure secondary to right heart 
failure or fluid overload reduces the pressure gradient for lymphatic 
flow into the innominate veins (150) and may explain the relatively
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low lymphatic absorption rates observed in these patients.
Alternatively reduced lymphatic drainage may be due to obstruction to 
lymphatic flow elsewhere in the substernal and diaphragmatic
pathways.
The role of lymphatic absorption from the peritoneal cavity in 
the pathophysiology of these different forms of ascites is summarised 
in Table 3.
TABLE 3; TRANSCAPILLARY FLUID INFLUX AND LYMPHATIC ABSORPTION RATES 
IN ASCITES
ASCITES NET TRANSCAPILLARY FLUID 
INFLUX RATE
LYMPHATIC ABSORPTION 
RATE
Hepatic ++++ ++
Malignant + -
Nephrogenic + -
Peritoneal Dialysis +++ + ?
Abbreviations: + increase
decrease
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Chapter 4. ROLE OF LYMPHATIC ABSORPTION IN PERITONEAL DIALYSIS
4.1 RATIONALE
Despite the importance of peritoneal cavity lymphatic absorption 
in the pathophysiology of ascites, the role of lymphatic drainage in 
the kinetics of peritoneal dialysis "ascites" has been disregarded 
(Table 3). Several theoretical and clinical considerations, however, 
suggest that lymphatic absorption may significantly reduce net 
ultrafiltration and solute mass transfer in peritoneal dialysis.
4.1.1 ANALOGY WITH ASCITES
Previous studies in ascitic patients indicate that lymphatic 
drainage exceeds 50 ml per hour unless the diaphragmatic or
mediastinal lymphatics are obstructed by tumour or fibrosis (131).
Intraperitoneal fluid volumes during peritoneal dialysis in adults
routinely exceed 2 litres and should also ensure continuous contact 
of fluid with the undersurface of the diaphragm. Moreover, the 
patency of the peritoneal cavity lymphatics should be preserved if 
the subdiaphragmatic parietal peritoneum only undergoes the same 
minor histological changes following long-term peritoneal dialysis as 
the parietal peritoneum lining the anterior abdominal wall (15-17).
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4.1.2 INTERSTITIAL LYMPHATICS
Ultrafiltrate from the peritoneal capillaries reaches the 
peritoneal cavity via pathways through the interstitium and so must 
bypass absorption by the interstitial lymphatics. Small increments 
in interstitial hydrostatic pressure increase the lymphatic flow rate 
until a maximum is reached when tissue hydrostatic pressure is 2 mmHg 
above normal (151). Although the hydrostatic pressure within the 
peritoneal interstitium is unknown, submesothelial oedema is often 
observed in specimens of peritoneum from patients on peritoneal 
dialysis (15,16) and may enhance fluid absorption by the interstitial 
lymphatics.
4.1.3 KINETICS OF HYPOTONIC INTRAPERITONEAL FLUID
Intraperitoneal fluid is absorbed continuously by convective 
flow via the peritoneal cavity lymphatics, regardless of the 
prevailing tonicity of the dialysis solution. In contrast net 
transcapillary absorption of fluid only occurs if the dialysis 
solution is hypotonic to plasma (110,152,153). After instillation of 
hypotonic or hypertonic solutions into the peritoneal cavity, net 
transcapillary absorption or ultrafiltration respectively continue 
until osmotic equilibrium is reached (Figures 5 and 6). Thereafter, 
the intraperitoneal fluid remains isosmotic, net transcapillary fluid 
transport is nearly zero and the intraperitoneal fluid volume is 
decreased at a linear rate by lymphatic absorption. Consequently only
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Osmolality
(mOsm/L)
^ = r = r = r = —  Plasma 
I.P. Solution
Intraperitoneal 
Volume
Dwell Time (Hrs)
\
Volume of Transcapillary 
and Lymphatic Absorption
Volume of Lymphatic 
±  Venular Oncotic Absorption
Dwell Time (Hrs)
Equilibration Post*Equ i libration 
Phase Phase
Figure 5: Changes in osmolality and intraperitoneal fluid volume 
following infusion of a hypotonic crystalloid solution. 
The equilibration volume (point A) coincides with 
crystalloid osmotic equilibrium (point B).
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Osmolality
(mOsm/L)
\  I.P. Solution 
\
\
B
rsrvswr Plasma
Dwell Time (Hrs)
Intraperitoneal
Volume
Equilibration Phase
Volume of 
Net Absorption
Total Volume 
of Lymphatic Absorption
Dwell Time (Hrs)
Figure 6: Changes in osmolality and intraperitoneal fluid volume 
following infusion of a hypertonic dextrose dialysis 
solution. The peak intraperitoneal volume (point A) 
precedes osmolar equilibrium (point B). Thereafter net 
fluid absorption represents lymphatic absorption in excess 
of net transcapillary ultrafiltration.
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with initially hypotonic solutions is intraperitoneal fluid 
absorption both transcapillary and translymphatic (Figure 5).
An average of 546 ml of fluid was absorbed over seven hours in 9 
uraemic patients after infusion of almost 2 litres of 0.9% saline 
(308 mOsm/L) into the peritoneal cavity (154). The average 
absorption rate of 78 ml per hour may, however, include net 
transcapillary absorption of fluid early in the dwell time due to an 
osmotic gradient between the infused 0.9% saline and uraemic plasma.
4.1.4 KINETICS OF ISOTONIC INTRAPERITONEAL FLUID
Absorption of intraperitoneal isosmotic fluid is primarily 
translymphatic (86-88,108-114). After 1 litre of 0.9% saline 
reached osmotic equilibrium with the plasma at two hours, the 
isosmotic fluid was then absorbed at a linear rate, which ranged from 
30 to 37 ml per hour and averaged 33 ml per hour in the four patients 
(110). This study, however, overestimated the intraperitoneal volume 
later in the dwell time and thus underestimated actual fluid 
absorption. The intraperitoneal volumes during the eight hour dwell 
time were calculated from the dilution of a single dose of radio- 
iodinated serum albumin. The quantity of the tracer colloid 
remaining in the peritoneal cavity was corrected for losses in 
dialysate samples and urine and for mass transfer to the estimated 
plasma volume. However only 10-30% of the radio-iodinated serum 
albumin absorbed from the peritoneal cavity appears in the plasma 
volume during the study time (64,102,128,154-156). Consequently the
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calculations overestimated the quantity of the radio-labelled 
colloid remaining in the peritoneal cavity, and so overestimated the 
intraperitoneal volume later in the dwell time. Nevertheless, even 
at less than half of the usual intraperitoneal fluid volume of adults 
on CAPD, the rate of lymphatic absorption from the peritoneal cavity 
is considerable.
4.1.5 KINETICS OF HYPERTONIC INTRAPERITONEAL FLUID
In hypertonic peritoneal dialysis, the intraperitoneal volume 
begins to decrease before isosmolality of the dialysis solution and 
plasma is observed (26,29), indicating that net fluid absorption 
occurs before net transcapillary ultrafiltration is complete (Figure 
6). Moreover, osmolar equilibrium is reached before osmotic and 
glucose equilibrium (26). The dialysis solution becomes isosmolar 
with the plasma before glucose equilibrium because of solute sieving 
with transcapillary ultrafiltration. The total transperitoneal 
osmotic pressure gradient is the sum of the products of the 
concentration gradient and the peritoneal reflection coefficient of 
each solute. Consequently the higher peritoneal reflection
coefficient of glucose than other small molecular weight solutes 
(157) maintains the osmotic pressure gradient into the dialysis 
solution and allows net transcapillary ultrafiltration to continue at 
a slow rate until crystalloid osmotic equilibrium is approached later 
in the dwell time. The dialysis solution may become hyposmolar to 
plasma and this further suggests that net transcapillary
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ultrafiltration continues after osmolar equilibrium is first reached. 
Thus the decrease in intraperitoneal volume ( AV) after peak 
ultrafiltration really represents the lymphatic absorption rate (Fl ) 
in excess of the net transcapillary ultrafiltration rate (J^ in 
equation 2). That is:
A V  = Lp A ( A it +AP) - F^ .....equation 6
Direct measurements of drain volumes after sequential dwell 
times in 29 CAPD patients showed that the rate of decrease in the 
intraperitoneal volume ranged from 8 to 89 ml per hour and averaged
39 ml per hour (25,26). The net absorption rate was not
significantly different, irrespective of whether 2 litre volumes of 
1.5%, 2.5% or A.25% dextrose dialysis solution were infused (25,26). 
Furthermore, net fluid absorption rates during dialysis with 2.5 
litre infusion volumes also averaged 37 ml per hour in 16 CAPD 
patients (23). Thus, the daily average lymphatic absorption rate 
during CAPD may be indirectly estimated to exceed 1 litre per day.
4.2 DEFINITIONS
4.2.1 NET ULTRAFILTRATION
The measurable net ultrafiltration volume represents the net 
change in the intraperitoneal volume at the end of the dwell time
and, assuming the residual volume is constant, equals the drain
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volume minus the infusion volume. However the net ultrafiltration 
volume is, in effect, the difference between cumulative net
transcapillary ultrafiltration into the peritoneal cavity and
lymphatic absorption during the dwell time out of the peritoneal 
cavity (Figure 7). These two formulations of net ultrafiltration may 
be designated directly measured and calculated net ultrafiltration 
(UF), respectively. That is:
measured net UF = drain volume - infusion volume
calculated net UF = cumulative net transcapillary UF - lymphatic
absorption
Blood 
Volume
Transperitoneal Transport
A .  Lymphatic 
Absorption
Dialysate ^  f  
Volume 
Infused '  I
Intraperitoneal
Volume
Dram 
■?* Volume
in
£
Figure 7: Schematic representation of the role of lymphatic 
absorption in the kinetics of peritoneal dialysis.
4.2*2 CUMULATIVE NET TRANSCAPILLARY ULTRAFILTRATION
Cumulative net transcapillary ultrafiltration defines the total 
net influx of fluid from the peritoneal microcirculation into the 
peritoneal cavity during the dwell time in response to the osmotic 
pressure of the dialysis solution. This definition allows for 
bidirectional transcapillary water movement during the dwell time and 
acknowledges that inflow into the peritoneal cavity dominates and 
that only the net fluid flux can be measured. Measured net 
ultrafiltration would equal the resultant net inflow of fluid if it 
was not for lymphatic absorption during the dwell time.
4.3 EFFECT OF LYMPHATIC ABSORPTION ON PERITONEAL DIALYSIS
The physiological roles of the peritoneal cavity lymphatics in 
the absorption of intraperitoneal isosmotic fluid, macromolecules, 
particles and bacteria are normally beneficial but have adverse 
consequences in peritoneal dialysis.
4.3.1 ABSORPTION OF INTRAPERITONEAL FLUID
Lymphatic drainage of intraperitoneal fluid throughout the dwell 
time will reduce the potential drain volume and consequently decrease 
both net ultrafiltration and solute mass transfer (18,22). During 
long-dwell exchanges lymphatic absorption is continuous, whereas net 
transcapillary ultrafiltration occurs mainly in the first hours of
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the exchange. Thus fluid absorption via the lymphatics has a greater 
influence on ultrafiltration kinetics in CAPD than in intermittent 
peritoneal dialysis with rapid exchanges. In short-dwell exchanges 
cumulative net transcapillary ultrafiltration greatly exceeds 
lymphatic drainage and the reduction in the drain volume, due to 
lymphatic absorption, is relatively minor.
The contribution of lymphatic absorption to ultrafiltration 
kinetics in CAPD has several implications. Firstly, even if 
lymphatic drainage remains unchanged with time on CAPD, reduction of 
the intraperitoneal fluid volume by lymphatic absorption may become 
relatively more important if increases in peritoneal permeability x 
area reduce cumulative net transcapillary ultrafiltration, as in Type 
I membrane failure (41-43). The contribution of intraperitoneal 
fluid absorption to reduced net ultrafiltration in Type I membrane 
failure can be demonstrated by decreasing the dwell time, which 
captures maximum, albeit relatively low, ultrafiltration (158).
Secondly, calculations of transperitoneal ultrafiltration and
solute transport which are based on the drain volume and drain 
dialysate solute concentration are erroneously low, since no 
allowance has been made for translymphatic absorption during the
dwell time. Thus the efficiency of the peritoneal dialysing membrane
is greater than previously recognised (24,57-59,64-66) and reduction 
of lymphatic absorption may provide an alternative means of
increasing net ultrafiltration and solute mass transfer without 
increasing transperitoneal transport of water and solutes.
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4*3*2 ABSORPTION OF INTRAPERITONEAL POLYMERS AND PARTICLES
Less absorbable osmotic agents than glucose have been sought to 
reduce the undesired metabolic sequelae of absorbed glucose and, most 
importantly, to induce sustained net transcapillary ultrafiltration 
(28,32,159-161). Despite initial promising results, the routine 
clinical use of glucose polymer has been limited by its systemic 
absorption and potential toxicity (159,160). Lymphatic drainage 
results in the systemic absorption of all polymer osmotic agents, 
regardless of their molecular weight, and will hinder, if not 
prevent, the development of effective and safe, alternative osmotic 
agents. Likewise any particulate matter which enters the peritoneal 
cavity in the dialysis solution will be potentially absorbed by the 
peritoneal cavity lymphatics. Thus contaminants in commercial 
dialysis solutions should be avoided to prevent their systemic 
accumulation and toxicity as well as their potentially adverse 
effects on the peritoneal membrane (39,162).
4.3.3 ABSORPTION OF INTRAPERITONEAL BACTERIA
Despite the uptake of bacteria by the peritoneal cavity
lymphatics (105,106), blood cultures are infrequently positive 
during CAPD associated peritonitis (163). Moreover, secondary 
pulmonary infections or right sided endocarditis are very rare
complications of peritonitis (104,163). The bacteria are presumably
filtered and effectively trapped by the mediastinal lymph nodes. The
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contractility of the lymphatic trunks is increased by leukotrienes 
and prostaglandins (164) and these mediators of inflammation are 
transiently elevated in the dialysis solution of patients with 
peritonitis (165). Consequently loss of ultrafiltration during 
peritonitis may be related to an increase in lymphatic absorption as 
well as to enhanced peritoneal permeability and increased absorption 
of glucose from the dialysate.
4.4 ESTIMATION OF LYMPHATIC ABSORPTION IN PERITONEAL DIALYSIS
Peritoneal lymphatic flow rates in hypertonic peritoneal 
dialysis cannot be quantitated directly since, later in the dwell 
time, net fluid absorption represents the lymphatic absorption rate 
in excess of the net transcapillary ultrafiltration rate (equation 
6). Thus, lymphatic drainage in peritoneal dialysis, as in ascites, 
can only be estimated indirectly.
Since the peritoneal cavity lymphatics drain intraperitoneal 
fluid by convective flow without increase or decrease in the 
concentration of index colloids (111,112,126-128) and 
intraperitoneal macromolecules are returned to the systemic 
circulation almost exclusively by the lymphatics (89,102,124,125), 
the lymphatic absorption rate may be estimated either from the mass 
transfer rate of index colloids from the peritoneal cavity to the 
blood or from their rate of disappearance from the peritoneal 
cavity.
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A.4*1 HASS TRANSFER RATES OF INTRAPERITONEAL COLLOIDS TO THE BLOOD
Peritoneal to blood clearances of radio-labelled colloids 
(equation 5) are a good index of the relative lymphatic absorption 
rates in different forms of ascites (128,130-134). However, the 
plasma appearance rate of an intraperitoneal index colloid 
underestimates the absolute lymphatic absorption rate for several 
reasons:
a) A significant proportion of the tracer colloid, absorbed by the 
subdiaphragmatic lymphatics, does not reach the systemic 
circulation during the study time due to delayed transit or 
permanent entrapment in the diaphragmatic and mediastinal lymph 
nodes. Indeed, this physiological function of the draining 
lymph nodes is utilised in mediastinal lymphoscintigraphy (131- 
134,166).
b) During the study time there is an initial lag phase before the 
plasma concentration of the radio-colloid begins to increase 
linearly as predicted (92,128,130,131).
c) The rise in concentration of the tracer colloid must be 
corrected for redistribution of the tracer out of the blood 
volume during the study interval (92,102,128).
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Consequently, the lymphatic absorption rate calculated by this 
method is significantly lower than direct observations of absorption 
of plasma or whole blood in the same animal model (86,92). Likewise 
in 10 CAPD patients the average lymphatic flow rate, calculated from 
the peritoneal to blood clearance of radio-iodinated serum albumin, 
was only 11 ml per hour (156), compared with the aforementioned 
estimate from serial drain volumes of at least 39 ml per hour (25, 
26). The lymphatic absorption rate in this study was underestimated 
since the plasma volume of the CAPD patients was extrapolated from 
their body weight, the elimination rate of the radio-colloid from the 
plasma was not included in the calculations and, most importantly, 
the plasma appearance rate of radio-iodinated serum albumin during 
the dwell time was only 20% of the peritoneal disappearance rate. 
Spencer and Farrell have shown that the mass transfer of
intraperitoneal radio-iodinated albumin to the blood in CAPD patients 
is significantly greater after 24 hours than at the end of a four 
hour study exchange (64). Thus lymphatic transfer of radio-colloids 
continues after the washout exchange at the end of the study time and 
cannot be related accurately to the duration of the exchange.
4.4.2 MASS TRANSFER RATES OF COLLOIDS FROM THE PERITONEAL CAVITY
Alternatively the lymphatic absorption rate (F^) may be
estimated from the mass transfer rate of intraperitoneal
macromolecules from the peritoneal cavity. That is:
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(v0 X c0 ) - (vt x ct)
Fj =     equation 7.
CP
= intraperitoneal fluid volumes at times 0 and t 
= intraperitoneal concentration of marker colloid at 
times 0 and t 
= time averaged mean intraperitoneal concentration 
of marker colloid
balance equation avoids the error in calculating 
lymphatic flow in the previous method due to delayed transfer of 
radio-labelled colloids from the diaphragm and interstitial
lymphatics to the blood. This formulation, however, not only
depends on the assumption that intraperitoneal macromolecules are 
absorbed exclusively from the peritoneal cavity by convective flow 
via the lymphatics (124-128), but further assumes that all of the 
intraperitoneal marker colloid lost from the peritoneal cavity is 
absorbed by the non-restrictive pathways of the lymphatics. In 
connective tissue spaces, back diffusion of colloids into 
capillaries is negligible (167), the osmolality and the concentration 
of protein in the tissue fluid and end lymphatic lymph are equal 
(151,168) and absorption of tissue protein is fully accounted for by 
lymphatic flow (167,169). Several observations indicate that these 
findings also pertain to intraperitoneal fluid and colloid kinetics 
and that intraperitoneal fluid absorption may be estimated from the 
rate of loss of an intraperitoneal marker colloid.
where V q  and Vt 
C q  and C|-
CP
This mass
a) The concentration of marker colloids or albumin remains
unchanged during absorption of intraperitoneal isosmotic fluid 
(86,92,102), suggesting that colloids are absorbed with fluid 
by convective transport through lymphatic pathways.
b) Fractional peritoneal absorption of albumin and IgG (128) and
dextrans of different molecular weight (170) are similar,
further suggesting that absorption of macromolecules is by 
convective flow.
c) The intraperitoneal content of radio-iodinated serum albumin
during hypertonic peritoneal dialysis decreases at a linear rate 
averaging 3% per hour (156) and, late in the dwell time, 
correlates with net fluid absorption (29,156).
However, with microquantities of radio-colloid, a significant
proportion of the administered dosage may be adsorbed to the 
peritoneal mesothelium, dialysis bag and administration set or be 
absorbed by the adjacent subperitoneal tissues (92,129,156). The 
addition of a large quantity of unlabelled colloid, such as albumin, 
instead of microamounts of radio-labelled colloid should only allow 
an insignificant fraction to be sequestered and so obviate this 
potential error. Thus, peritoneal cavity lymphatic absorption 
theoretically may be most accurately estimated from the net rate of 
removal of a high intraperitoneal concentration of unlabelled colloid 
from the peritoneal cavity (equation 7).
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This method also requires accurate estimates of the 
intraperitoneal volume and serial samples of the intraperitoneal 
fluid. Both of these requirements can be achieved more easily in 
peritoneal dialysis patients than in patients with ascites, since 
CAPD patients have peritoneal catheters in-situ and both the infusion 
and drain volumes can be directly measured.
4.5 CONCLUSION
The role of lymphatic absorption in the kinetics of peritoneal 
dialysis has been disregarded (Chapter 1), even though the 
physiological absorptive capacity of the peritoneal cavity 
lymphatics is considerable (Chapter 2) and the importance of 
peritoneal lymphatic drainage in the pathophysiology of ascites is 
well established (Chapter 3). Indirect evidence indicates that 
lymphatic absorption in peritoneal dialysis may exceed 1 litre per 
day and thereby significantly alter ultrafiltration kinetics and 
reduce the efficiency of long-dwell peritoneal dialysis (Chapter 4).
The following studies were performed to resolve these issues.
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PART II STUDTKS OF LYMPHATIC ABSORPTION IN PERITONEAL DIALYSIS
Chapter 5. LYMPHATIC ABSORPTION IN PERITONEAL DIALYSIS IN THE RAT
5.1 INTRODUCTION
The role of lymphatic absorption in the kinetics of 
ultrafiltration in peritoneal dialysis was evaluated during single 
six hour exchanges in rats using 15% dextrose dialysis solution. In 
this small animal model of peritoneal dialysis, serial direct 
measurements of net ultrafiltration and intraperitoneal volume can be 
compared with concurrent lymphatic absorption rates calculated from 
peritoneal clearances of rat albumin added to the dialysis solution. 
The albumin method for estimating the lymphatic absorption rate was 
assessed .in parallel studies in rats using Ringer's lactate instead 
of hypertonic dextrose dialysis solution, where the net fluid 
absorption rate from the peritoneal cavity can be measured directly.
5.2 METHODS
5.2.1 THE RAT MODEL OF PERITONEAL DIALYSIS
After induction of anaesthesia with 50 mg per Kg subcutaneous 
pentobarbital sodium (Nembutal, Abbott Laboratories, Chicago, 
Illinois), male Sprague-Dawley rats were placed supine on a heating 
pad maintained at 37° C. Body temperature was monitored with a 
rectal temperature probe (Yellow Springs Instruments Inc., model 
402), and anaesthesia maintained with supplemental subcutaneous
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injections of 2.5 mg Nembutal as required. A Tenckhoff-type 
peritoneal catheter was passed through a small midline incision 1 cm 
below the xiphoid process and advanced into the peritoneal cavity 
with the tip directed towards the right lower quadrant of the 
abdomen. The external jugular vein was cannulated using Intramedic 
polyethylene tubing (Clay Adams, Parsippany, New Jersey), and the 
animals hydrated by infusion of warm Ringer's lactate solution 
(Baxter-Travenol Co., Deerfield, Illinois) at a rate of 8.8 to 13.3 
ml per hour using a syringe pump (Sage instruments, model 341). 
Peritoneal exchanges were not begun until each rat was undergoing 
spontaneous diuresis, usually 60 to 90 mins after the intravenous 
infusion was commenced. The infusion rate was continued during the
hypertonic exchanges to replace losses due to peritoneal
ultrafiltration but was discontinued during the exchanges using
Ringer's lactate solution.
5.2.2 EXCHANGES USING 15% DEXTROSE DIALYSIS SOLUTION
Six rats (mean weight 530g, range 489-627g) underwent a six 
hour exchange using 16 ml of 15% anhydrous dextrose dialysis 
solution. An immediate in and out exchange with 40 ml of Ringer's 
lactate solution was performed in each rat prior to the study 
exchange to determine the intraperitoneal residual volume. The 
hypertonic dialysis fluid was prepared by adding glucose to standard 
Dianeal PD-2 dialysis solution (Baxter-Travenol Co., Deerfield, 
Illinois). In three of the animals, rat albumin (Sigma Chemical Co.,
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St. Louis, Missouri) was added to the study dialysis solution to 
approach concentrations of 2.5% albumin.
The intraperitoneal volume at 30 mins and at the end of each 
hour was directly measured by rapid drainage into a graduated 
cylinder. Immediately after obtaining a sample (0.3 ml) from each 
drain volume, the dialysate was reinfused and the timer restarted. 
Complete drainage, sampling and reinfusion were performed within 5 
minutes and this interval was considered as a total interruption of 
peritoneal transport. Baseline and serial dialysate samples were 
analysed for glucose and albumin concentrations and osmolality. Tail 
vein blood was obtained at each time interval for haematocrit and 
glucose concentration and at baseline and 360 min for estimation of 
osmolality and albumin concentration. Porcine insulin, 0.1 U per g % 
dialysate dextrose, was administered intraperitoneally and thereafter 
as needed to maintain serum glucose less than 200 mg/dl. The 
intravenous infusion rate of Ringer's lactate was altered as required 
to keep the haematocrit constant.
5.2.3 EXCHANGES WITH RINGER'S LACTATE SOLUTION
Six rats (mean weight 355g, range 319-404g) underwent a similar 
six hour exchange using 40 ml Ringer's lactate solution (273 mOsm/L). 
Rat albumin was added to the dialysis solution in three of the rats 
as before to give a 2.5% albumin solution. The protocol was the same 
as during the 15% dextrose exchanges with the exceptions that the
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intravenous infusion was discontinued before beginning the study 
exchanges and no intraperitoneal insulin was administered.
5.2.4 LABORATORY METHODS
Albumin concentrations in serum and dialysate were measured in 
duplicate by the bromcresol green method (171). Glucose 
concentrations in the dialysate were measured by the ortho-toluidine 
method (172). Serum glucose concentrations were measured
immediately with a Chemstrip BG (Boehringer Mannheim Diagnostic Inc., 
Indianapolis, Indiana). Serum and dialysate osmolalities were 
measured using a Wescor 5100 B vapour pressure osmometer (Wescor 
Inc., Logan, Utah).
5.2.5 CALCULATIONS
The intraperitoneal residual volume was calculated as the 
difference between the instillation and drainage volumes of the in 
and out exchange. Consequently, the intraperitoneal fluid volume at 
the end of each study interval equalled the drainage volume for that 
time interval plus the residual volume of the in and out exchange.
The net ultrafiltration volume after each study interval during 
the exchanges with hypertonic glucose was calculated as the drain 
volume for the time interval minus the initial infusion volume. The 
net absorption volume after each time interval during the exchanges
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with Ringer's lactate was calculated as the instillation volume minus 
the drainage volume after the study interval.
Lymphatic absorption was estimated from the mass transfer rate 
of intraperitoneal albumin from the peritoneal cavity as described 
previously (equation 7). During each short time interval the average 
intraperitoneal albumin concentration (Cp) was calculated as the 
arithmetic mean of the corrected dialysate albumin concentrations at 
the beginning and end of the study interval. The corrected albumin 
concentration at each time interval in rats with albumin added to the 
dialysis solution was calculated as the measured albumin 
concentration minus the mean albumin concentration at the same time 
interval in rats without albumin added to the dialysis solution. 
Although these corrections were small, they allowed for the albumin 
entry from the peritoneal microcirculation during the dwell time, 
which would otherwise result in slight underestimates of net removal 
of intraperitoneal albumin by the lymphatics. Accordingly lymphatic 
absorption (ml) per time interval (t to t* min) equals
(Ct x Vt) - (Ct* x Vt’)
(Ct + C t')/2
where Ct and Ct' - corrected albumin concentrations at
and t',respectively.
V^. and Vt' = intraperitoneal volumes at times t 
respectively.
times t
i
and t ,
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Cumulative lymphatic absorption was calculated as the 
progressive sum of interval measurements. Cumulative net 
transcapillary ultrafiltration was estimated by adding cumulative 
lymphatic absorption and cumulative measured net ultrafiltration. 
Mean interval rates were calculated by dividing changes per interval 
by the duration of the interval. Results were compared by Student's 
non-paired t test and correlation coefficients were calculated by 
linear regression.
5.3 RESULTS
5.3.1 EXCHANGES WITH 15% DEXTROSE DIALYSIS SOLUTION
Cumulative net ultrafiltration, cumulative lymphatic absorption 
and laboratory results during exchanges with 15% dextrose dialysis 
solution are summarised in Table 4. The mean intraperitoneal
residual volume was 1.0 ± 0.3 (SEM) ml. The intraperitoneal fluid 
volume increased from 17 ± 0.3 ml at the beginning of the exchange to 
41 ± 2.4 ml after six hours. Cumulative net ultrafiltration and 
cumulative lymphatic absorption related to dwell time are shown in 
Figure 8. Cumulative net ultrafiltration began to decrease after 
four hours while cumulative lymphatic absorption increased 
progressively throughout the dwell time. Cumulative net
transcapillary ultrafiltration (actual transperitoneal ultra­
filtration) was calculated as the sum of net ultrafiltration and 
lymphatic absorption after each time interval (Figure 9). At the end
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Figure 8: Cumulative lymphatic absorption and cumulative net 
ultrafiltration (mean ± SEM) during six hour exchanges 
with 15% dextrose dialysis solution in rats.
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Figure 9: Cumulative lymphatic absorption (mean ± SEM) and 
cumulative net transcapillary ultrafiltration during six 
hour exchanges with 15% dextrose dialysis solution in 
rats.
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of the six hour exchanges 5A ± 5% of the actual transperitoneal
ultrafiltration had been reabsorbed by the peritoneal cavity 
lymphatics. That is, net ultrafiltration at the end of the dwell 
averaged 24 ± 2 ml whereas actual transperitoneal ultrafiltration
averaged 52 ± 5 ml.
The net ultrafiltration volume and, thus the intraperitoneal 
volume, reached a maximum during the relative plateau phase between 
two and four hours dwell time (Table A, Figure 8). The relationships 
of dialysate and serum osmolality and glucose concentrations to this 
intraperitoneal volume plateau phase are shown in Figure 10. 
Dialysate osmolality decreased almost exponentially and at six hours 
was significantly below serum osmolality (p < 0.05) even though
dialysate glucose was still significantly higher than serum glucose 
(p < 0.01). As a result, the intraperitoneal volume plateau phase 
precedes osmolar equilibrium between serum and the dialysis solution 
and osmolar equilibrium precedes glucose equilibrium (Figure 10, 
Table A).
Net transcapillary ultrafiltration and lymphatic absorption 
rates during each time interval are plotted in Figure 11. The net 
transcapillary ultrafiltration rate decreased at an exponential rate 
but did not reach zero until near the end of the dwell time. 
Lymphatic absorption is depicted as a mean rate over the entire 
dwell time since cumulative lymphatic absorption proceeded at a 
linear rate averaging A.7 ± 0.9 ml per hour (Figure 9). The temporal 
relationships to peak intraperitoneal volume, osmolar equilibrium and 
glucose equilibrium are also shown in Figure 11. The maximum
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Dialysate and serum osmolalities and glucose 
concentrations (mean ± SEM) are related to dwell time 
and intraperitoneal volume in exchanges with 15% 
dextrose dialysis solution in rats. The period of 
maximum intraperitoneal volume is indicated.
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Figure 11: The net transcapillary ultrafiltration rate (mean ±
SEM) and mean lymphatic absorption rate are related to 
dwell time and key events during exchanges with 15% 
dextrose dialysis solution in rats. The peak 
intraperitoneal volume precedes osmotic equilibrium 
which in turn precedes glucose equilibrium.
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intraperitoneal volume occurred when the net transcapillary
ultrafiltration rate equalled the lymphatic absorption rate. At this 
point the net ultrafiltration rate was zero. Thereafter the 
intraperitoneal volume decreased, even though net transcapillary
ultrafiltration continued at a slow rate and osmolar equilibrium was 
not reached until slightly later in the dwell time. After osmolar 
equilibrium the dialysate became hyposmolar to serum, presumably as 
a result of continued net transcapillary ultrafiltration and solute 
sieving. Glucose dysequilibrium persisted throughout this hyposmolar 
phase until the end of the study dwell time.
Despite attempts at preventing hyperglycaemia using 
intraperitoneal insulin, a minor rise in serum glucose was observed
early in the dwell time during peak glucose absorption from the
dialysate (Table 4). However, this transient rise in serum glucose 
did not significantly reduce the transperitoneal osmolar gradient. 
The haematocrit also rose transiently during peak net transcapillary 
ultrafiltration early in the dwell time in spite of the intravenous 
infusion of Ringer's lactate to replace ultrafiltration losses as 
they occurred (Table 4).
5.3.2 EXCHANGES WITH RINGER'S LACTATE
Cumulative net fluid absorption, cumulative lymphatic absorption 
and laboratory results during exchanges with Ringer's lactate 
solution are summarised in Table 5. The initial mean intraperitoneal 
fluid volume decreased from 41 ± 0.4 ml to 25 ± 1.4 ml at the end of
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the dwell time. Cumulative directly measured net fluid absorption 
and cumulative lymphatic absorption are compared in Figure 12. 
Measured net fluid absorption slightly exceeded lymphatic absorption 
early in the dwell time due to the initial transperitoneal osmotic 
gradient favouring net transcapillary absorption. Thereafter net 
fluid absorption proceeded at an almost linear rate, the corrected 
dialysate albumin concentration remained relatively constant as the 
intraperitoneal volume decreased, and measured net fluid absorption 
was closely correlated with the calculated lymphatic absorption rate 
(r = 0.98; p < 0.01) (Figure 12, Table 4). The haematocrit and serum 
osmolality also remained almost constant during the absorption of 
Ringer's lactate solution from the peritoneal cavity, indicating 
that the animals were able to diurese most of the fluid and 
electrolytes as they were absorbed (Table 5).
Cumulative lymphatic absorption rates during exchanges with 
Ringer's lactate were lower than in the studies with 15% dextrose 
dialysis solution (Figure 13). However, when expressed in relation 
to the animal's body weight, mean lymphatic absorption rates with the 
two dialysis solutions were nearly identical (Figure 14) even though 
the intraperitoneal volume decreased from 41 to 25 ml with Ringer's 
lactate and increased from 17 to 41 ml with hypertonic dextrose 
dialysis solution.
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LACTATED RINGER'S ABSORPTION
Figure 12:
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Cumulative lymphatic absorption (mean ± SEM), 
calculated by the albumin absorption method, is 
related to directly measured fluid absorption (mean ± 
SEM) during six hour exchanges with Ringer's lactate 
solution in rats. The identity line is shown.
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5*4 DISCUSSION
This study indicates that lymphatic absorption of 
intraperitoneal fluid during peritoneal dialysis exchanges with 15% 
dextrose dialysis solution is substantial, and significantly reduces 
the potential net ultrafiltration volume at the end of the exchanges. 
Thus, measured net ultrafiltration at the end of the six hour 
exchanges averaged only 46% of the calculated cumulative net 
transcapillary ultrafiltration over the dwell time. Since the net 
transcapillary ultrafiltration rate decreases exponentially during 
the dwell time while the lymphatic absorption rate remains almost 
constant throughout the exchange, prolonging the dwell time or 
reducing the dialysate glucose load (osmolality or volume of dextrose 
dialysis solution) in the above studies would be expected to increase 
the proportion of net transcapillary ultrafiltration reabsorbed by 
the peritoneal cavity lymphatics.
A very high dialysate dextrose concentration was used in these 
studies to permit more accurate measurements of net ultrafiltration 
in the small animal model of peritoneal dialysis, and thereby more 
clearly delineate the kinetics of ultrafiltration during the dwell 
time. In previous studies using 15% dextrose dialysis solution in 
the rat, no acute alterations in peritoneal morphology or transport 
characteristics were observed (173). Maximum net ultrafiltration 
rates in that study were between 0.4 and 0.5 ml/hour and are 
comparable with the results presented herein (Figure 11).
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The peak ultrafiltration volume precedes transperitoneal osmolar 
equilibrium which in turn precedes glucose equilibrium (Figure 11). 
The maximum intraperitoneal volume is observed when the net 
transcapillary ultrafiltration rate falls to equal the lymphatic 
absorption rate. In the above studies maximum intraperitoneal volume 
occurred while the transperitoneal osmotic gradient was still high 
enough to induce net transcapillary ultrafiltration at approximately 
4.7 ml per hour. Thus peak ultrafiltration occurs before net 
transcapillary ultrafiltration ceases and before osmolar equilibrium 
is reached. After peak ultrafiltration, the net fluid absorption 
rate represents lymphatic absorption in excess of concurrent net 
transcapillary ultrafiltration. The hyposmolar phase after osmolar 
equilibrium most likely reflects solute sieving with continued net 
transcapillary ultrafiltration. Since osmotic pressure is the sum of 
the products of the osmolar gradient and peritoneal reflection 
coefficient of each solute, the minor net transcapillary 
ultrafiltration rate after osmolar equilibrium is presumably related 
to glucose dysequilibrium and the higher peritoneal reflection 
coefficient of glucose than other small molecular weight solutes 
(157,174). This mechanism also has been invoked to explain the net 
ultrafiltration observed following intraperitoneal instillation of 
electrolyte-free 5% dextrose solution (252 mOsm/L) (157).
During the exchanges with Ringer’s lactate solution net fluid 
absorption proceeded at a linear rate after osmolar equilibrium was 
approached during the first two hours of the dwell time. The 
lymphatic absorption rate, calculated by the albumin method, was also
102
relatively constant during Ringer's lactate exchanges and closely 
correlated with the directly measured net fluid absorption rate (r =
0.98) (Figure 12). Moreover, in the present and in previous studies 
(92,102), the concentrations of intraperitoneal marker colloids 
remained almost constant during absorption of near isosmotic 
crystalloid solutions, and further suggest that the intraperitoneal 
fluid was absorbed by convective flow via the peritoneal cavity 
lymphatics. Thus, under the conditions of these long-dwell studies, 
the absorption of intraperitoneal Ringer's lactate is mainly 
translymphatic. These findings also validate the method of 
estimating lymphatic flow from the peritoneal clearance of albumin 
added to the dialysis solution.
The net fluid absorption rates after infusion of AO ml of 
Ringer's lactate averaged 2.6 ml per hour (7.3 ml/Kg/hour) throughout 
the exchange and 2.2 ml per hour (6.2 ml/Kg/hour) during the final 
four hours of the dwell time and are in accord with previous studies 
in rats (92,108). Following infusion of 33 to AO ml of Krebs-Ringer 
solution with 5% bovine serum albumin, net fluid absorption averaged
2.1 ml per hour (10 ml/Kg/hour) (92) and following infusion of 20 
ml/Kg of homologous plasma, net absorption averaged 6 ml/Kg/hour 
(108).
The lymphatic absorption rates during the exchanges with 
hypertonic dextrose and Ringer's lactate solution were comparable 
when corrected for body weight. The physiological factors which are 
known to influence the lymphatic absorption rate of intraperitoneal 
fluid were also similar in both groups of rats (Table 2). All of the
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study rats were maintained supine under general anaesthesia and the 
average intraperitoneal volumes were comparable in each group of 
rats, even though the intraperitoneal volume was decreasing with 
Ringer's lactate and increasing during 15% dextrose exchanges.
5.5 CONCLUSIONS
1. Cumulative lymphatic absorption significantly alters 
ultrafiltration kinetics in peritoneal dialysis with hypertonic 
dextrose dialysis solutions in rats:
a) As a result of the substantial lymphatic absorption rate,
net ultrafiltration at the end of the dwell time is much
lower than cumulative net transcapillary ultrafiltration
during the exchange.
b) The net transcapillary ultrafiltration rate decreases
exponentially during the dwell time whereas lymphatic
absorption proceeds at an almost constant rate.
c) The peak ultrafiltration volume is observed when the net
transcapillary ultrafiltration rate equals the lymphatic 
absorption rate. Thereafter, net fluid absorption
represents lymphatic absorption in excess of concurrent net 
transcapillary ultrafiltration.
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2. The absorption of intraperitoneal Ringer's lactate solution 
during long-dwell exchanges in rats is primarily translymphatic:
a) Lymphatic absorption of Ringer's lactate solution proceeds 
at a linear rate and closely correlates with directly 
measured net fluid absorption.
b) The corrected dialysate albumin concentration remains 
relatively constant during absorption of the intra­
peritoneal fluid.
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Chapter 6. LYMPHATIC ABSORPTION IN ADULT PATIENTS ON CAPD
6.1 INTRODUCTION
Cumulative lymphatic absorption from the peritoneal cavity may 
significantly reduce net ultrafiltration and peritoneal solute
clearances at the end of long-dwell CAPD exchanges. Moreover, since 
net ultrafiltration represents cumulative net transcapillary
ultrafiltration minus cumulative lymphatic drainage over the dwell 
time, lymphatic absorption may be relatively more important in CAPD 
patients with high peritoneal permeability x area, rapid absorption 
of glucose from the dialysis solution and lower net transcapillary 
ultrafiltration. This study was performed to evaluate the 
contribution of lymphatic absorption to the loss of ultrafiltration 
and solute mass transfer during standardised exchanges in adult CAPD 
patients, and to compare the influence of lymphatic drainage on the 
kinetics of ultrafiltration in CAPD patients with normal and high 
peritoneal permeability x area.
6.2 METHODS
6.2.1 PATIENTS
Standardised, four hour study exchanges using 2 litres of 2.5% 
hydrated dextrose dialysis solution were performed in 18 stable CAPD 
patients (11 men, 7 women). The study was approved by the
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Institutional Review Board for Human Experimentation, University of 
Missouri-Columbia, and each patient gave informed, written consent. 
At the time of study, the mean age of patients was 59 ± 3 (SEM) years 
(range 28-81) and the mean duration of CAPD was 26 ± 7 months (range 
1-105). Although seven patients had had 20 prior episodes of
peritonitis, none of the patients had peritonitis within three months 
of study. All of the patients had used only lactate containing
dialysis solutions. None of the patients had clinical features of 
chronic liver disease and liver function tests (serum bilirubin, 
serum alanine aminotransferase and serum aspartate aminotransferase) 
were within normal limits in all of the patients. None of the 
patients had evidence of an extraperitoneal dialysate leakage and 
only one of the patients (patient 12) was slightly fluid overloaded 
(minimal ankle oedema, recent weight gain of 3 Kg) at the time of 
study.
The patients were divided into two groups using peritoneal 
transport rates (dialysate/serum urea and creatinine and 
effluent/initial dialysate glucose ratios) during the study exchanges 
as indices of peritoneal permeability x area (Figure 2) (60,61). Ten 
patients (group 1) had urea, creatinine and glucose ratios within the 
normal range (±1 SD) and eight patients (group 2) had dialysate/ 
serum urea and creatinine ratios greater than 1 SD above the mean and 
effluent/initial dialysate glucose ratios more than 1 SD below the 
mean of the CAPD population at the University of Missouri-Columbia 
(Figures 15,16 and 17). The demographic features of groups 1'and 2 
are summarised in Tables 6 and 7, respectively. The mean age,
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Figure 15:
-------1— ---- 1------- I------ 1—
1 2 3 4
Dwell Time (hours)
• — •  Normal Peritoneal Permeability x Area (Group 1) 
£ — A High Peritoneal Permeability x Area (Group 2)
Dialysate/serum urea ratios (mean ± SEM) during four ’ 
hour exchanges with 2 litres of 2.5% dextrose dialysis 
solution in groups 1 and 2. The reference range (mean 
± 1 SD) is shaded.
* p < 0.05.
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Normal Peritoneal Permeability x Area (Group 1) 
A— A  High Peritoneal Permeability x Area (Group 2)
Dialysate/serum creatinine ratios (mean ± SEM) during 
four hour exchanges with 2 litres of 2.5% dextrose 
dialysis solution in groups 1 and 2.
** p < 0.01 ; * p < 0.05.
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duration of CAPD and number of previous episodes of peritonitis did 
not differ between the two patient groups.
All of the patients in group 2 exhibited poor peritoneal 
ultrafiltration and only patients 13 and 14, with residual urine 
volumes in excess of 1 litre per day, did not require 2.5% or 4.25% 
dextrose dialysis solution for all CAPD exchanges. Patients 16 and 
17 needed short-dwell exchanges overnight using a cycler machine 
(nightly peritoneal dialysis) to maintain fluid balance (175).
6.2.2 STUDY EXCHANGES
Each study was performed after an overnight exchange (10-12 
hours) with 2 litres of 2.5% dextrose dialysis solution (Dianeal, 
Baxter-Travenol, Deerfield, Illinois). After complete drainage of 
the overnight dwell over 20 minutes, 2 litres of 2.5% dextrose 
dialysis solution with 30 g added albumin was infused over 10 
minutes. The study dialysis solution was prepared by preheating 2 
litres of 2.5% Dianeal PD-2 solution to 37°C, withdrawing 120 ml of 
the dialysate under aseptic technique and adding 120 ml of 25% human 
serum albumin (Baxter-Travenol, Deerfield, Illinois). During 
infusion of the dialysis solution the patient rolled from side to
side every two minutes to promote intraperitoneal mixing of the
dialysate. After complete infusion (time 0), the patient remained
supine for the four hour study exchange. After four hours the
dialysate was drained over 20 minutes, the drain volume measured in a
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graduated cylinder and 2 litres of fresh dialysis solution without 
albumin instilled.
Dialysate samples (10 ml) were obtained serially at times 0, 30, 
60, 120, and 180 minutes during the study dwell time, from each
infusion and drain volume, and immediately following complete
infusion of the wash-out exchange after the study dwell. Serial 
samples during the exchange were taken after draining 200 ml into the 
drain bag and inverting the bag three times. Immediately after each 
serial sample was obtained, the dialysate remaining in the drain bag 
was reinfused. Blood samples (10 ml) were drawn at the beginning and 
end of the study exchange.
Repeat study exchanges were performed in four patients within 
the next four days. Three of the patients were from group 1 and one 
from group 2 (patients 1, 3, 5 and 13). The above protocol was 
followed using 2 litres of Ringer's Lactate solution with 25 g
albumin instead of 2 litres of 2.5% dextrose, 1.5% albumin solution.
23.4% Na Cl was added to the Ringer's Lactate solution (273 mOsm/L) 
to correct the dialysate osmolality to each patient's measured serum 
osmolality. These studies enabled comparison of lymphatic absorption 
rates during four hour exchanges with equal volumes of isotonic and 
hypertonic intraperitoneal fluid. A third two hour study using 2 
litres of 2.5% dextrose dialysis solution without albumin was 
performed in the same four patients to compare peritoneal 
permeability x area during exchanges with and without added albumin 
as well as calculated and measured two hour intraperitoneal volumes.
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6.2.3 LABORATORY METHODS
Albumin, glucose, urea, creatinine, and potassium 
concentrations, osmolality and colloid osmotic pressure were measured 
in all samples. Serum glucose and dialysate and serum urea and 
creatinine concentrations were determined by standard automated 
methods (Autoanalyser II, Technicon Instruments Corp., Tarrytown, New 
York). Dialysate creatinine values were corrected for high dialysate 
glucose concentrations (176). Serum and dialysate potassium 
concentrations were measured using a flame photometer (model 343, 
Instrumentation Laboratories Inc., Lexington, Maryland). Serum and 
dialysate albumin concentrations and osmolality and dialysate glucose 
concentrations were measured as described previously (5.2.4). The 
mean difference between duplicate determinations of albumin
concentrations was 2.5 ± 0.3%. Colloid osmotic pressure was measured
using a Weil osmometer (Instrumentation Laboratories Inc.).
6.2.4 CALCULATIONS
Since intraperitoneal marker colloids are removed from the 
peritoneal cavity almost exclusively by convective flow via the
peritoneal cavity lymphatics (124-128), cumulative lymphatic 
absorption over the four hour dwell time was calculated from the net 
mass transfer of albumin from the peritoneal cavity during the 
exchange as discussed previously (equation 7, 4.4.2). Moreover, 
since lymphatic drainage during peritoneal dialysis in the rat
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proceeds at almost a linear rate throughout the exchange, the 
lymphatic absorption rate during CAPD exchanges was also assumed to 
be constant and was calculated by dividing cumulative lymphatic 
absorption by the dwell time.
Cumulative net transcapillary ultrafiltration was estimated from 
the dilution of the initial dialysate albumin concentration since the 
intraperitoneal albumin concentration is unchanged by lymphatic 
absorption of intraperitoneal fluid (111,112,126-128) and any 
decrease in the dialysate albumin concentration during the dwell 
time results from net influx of fluid from the peritoneal 
microcirculation.
The calculated net ultrafiltration volume at time intervals 
during the exchange was calculated as the difference between 
cumulative net transcapillary ultrafiltration and lymphatic 
absorption after each time interval. The calculated intraperitoneal 
volume at each time interval was calculated as the intraperitoneal 
volume at 0 hour dwell time plus the calculated net ultrafiltration 
after the time interval. The measured net ultrafiltration volume at 
the end of the four hour dwell time equalled the difference between 
the intraperitoneal volumes at the beginning and end of the exchange. 
That is:
1. Lymphatic absorption during the 4 hour dwell (ml) ~
(A0 x IPV0) - (A4 x IPV4)
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2. Cumulative net transcapillary UF (ml) after time t (hours) =
A0/At (IPV0) - (iPVg)
3. Calculated net UF (ml) at time t (hours) =
Cumulative net transcapillary UF - lymphatic absorption after 
time t
4. Calculated intraperitoneal volume (ml) after time t (hours) =
IPVq + calculated net UF at time t
5. Measured net UF at 4 hours (ml) = IPV4 “ -^^0
where Ag, A4, At = dialysate albumin concentrations at
times 0, 4 and t hours dwell time,
respectively 
Ag = geometric mean dialysate albumin
concentration 
= V Aq x A4
IPVg = intraperitoneal volume at 0 hour dwell 
time
= infusion volume (2070 ml) + pre­
exchange residual volume
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IPVA = intraperitoneal volume at 4 hour dwell
time
= drain volume + sample volume + post­
exchange residual volume
The geometric mean (Aq ) was utilised to represent the time
averaged mean intraperitoneal albumin concentration since the 
dialysate albumin concentration decreases almost exponentially during 
the exchange due to ultrafiltration. The pre- and post-exchange 
residual volumes were derived from the mean of each residual volume 
calculated from the change induced in the drain dialysate urea,
potassium, glucose and albumin concentrations by the known volume and 
solute concentrations of the newly infused dialysis solution. The 
average volume of dialysis solution in 2 litre bags of Dianeal PD-2 
was 2070 ml and was therefore used in all calculations based on the 
infusion volume.
The percentage glucose absorption from the dialysis solution 
during the exchange was calculated as:
IPV4 x G4 
q  __    ) x 100%
IPVQ x G0
where G q  and G4 = dialysate glucose concentrations at 0
and 4 hours, respectively
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Daily net transcapillary ultrafiltration and drain volumes using 
four exchanges of 2 litres, 2.5% dextrose dialysis solution per day 
were extrapolated by assuming that net transcapillary ultrafiltration 
was complete after four hours dwell time and lymphatic absorption was 
continuous at the observed rate. Daily solute clearances were 
calculated as the product of daily drain volume and drain dialysate 
solute concentration divided by the mean serum solute concentration, 
where the drain dialysate concentration was assumed to equal the four 
hour dwell time solute concentration. Reverse solute clearances (via 
lymphatics) were similarly calculated based on the mean dialysate 
solute concentration per exchange. Thus, reverse solute clearances 
equalled the product of daily lymphatic drainage and mean dialysate 
solute concentration divided by the mean serum solute concentration.
The results in groups 1 and 2 were compared by Student's non­
paired t test and correlation coefficients were derived by linear 
regression.
6.3 RESULTS
6.3.1 EXCHANGES WITH 2.5% DEXTROSE DIALYSIS SOLUTION WITH ADDED 
ALBUMIN
ALL PATIENTS
The mean cumulative lymphatic absorption from the peritoneal 
cavity during the four hour exchanges with 2 litres of 2.5% dextrose 
dialysis solution was 343 ± 39 (SEM) ml (Table 8). Cumulative net
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TABLE 8: CUMULATIVE LYMPHATIC ABSORPTION AND NET TRANS CAPILLARY
ULTRAFILTRATIQN DURING FOUR HOUR EXCHANGES WITH 2 LITRES OF 
2.5% DEXTROSE DIALYSIS SOLUTION
FLUID TRANSPORT 
(ml)
GROUPS 1 & 2 
(n=18)
GROUP 1 
(n=10)
GROUP 2 
(n=8)
Net TCUF at 30 min. 302 ± 34 334 ± 41 269 ± 49
Net TCUF at 60 min. 455 ± 42 468 ± 59 441 ± 64
Net TCUF at 120 min. 589 ± 56 639 ± 67 532 ± 88
Net TCUF at 180 min. 629+60 692 ± 77 548 ± 90
Net TCUF at 240 min. 686 ± 66 806 ± 77 536 ±92
Lymphatic Absorption
over 240 min. 343 ±39 332 ± 65 356 ± 36
Lymphatic Absorption/
Net TCUF at 240 min.(%) 54.4 ± 5.9 40.1 ± 6.0 72.1 ± 7.3
x Mean ± SEM values in groups 1 and 2 were compared by 
Student's non-paired t test. Net TCUF denotes cumulative net 
transcapillary ultrafiltration after the stated dwell time.
0.05
0.005
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transcapillary ultrafiltration and calculated net ultrafiltration at 
each time interval during the exchanges are summarised in Tables 8 
and 9, respectively. The influence of cumulative lymphatic 
absorption on the kinetics of ultrafiltration during the four 
exchanges is derived from these data and is shown in Figure 18. As a 
result of cumulative lymphatic absorption, peak net ultrafiltration 
occurred near the two hour dwell time and calculated net 
ultrafiltration at the end of the exchanges averaged only 44 ± 6% of
the total net transcapillary ultrafiltration volume during the dwell 
time (Figure 18 and Table 8). The calculated and directly measured 
net ultrafiltration volumes at the end of the exchanges correlated 
closely (r = 0.97; p < 0.0001), supporting the validity of the
methods (Table 9).
The mean rates of net transcapillary ultrafiltration and 
lymphatic absorption during the exchanges are depicted in Figure 19. 
The net transcapillary ultrafiltration rate decreased exponentially 
during the dwell time as expected, whereas lymphatic absorption was 
assumed to be constant throughout the exchange (5.3.1). Consequently 
the peak ultrafiltration volume occurred when the net transcapillary 
ultrafiltration rate had decreased to equal the lymphatic absorption 
rate. At this point the net ultrafiltration rate was zero. 
Subsequently, the net absorption rate represented the lymphatic 
absorption rate in excess of the concurrent net transcapillary 
ultrafiltration rate (Figure 19).
Dialysate and serum osmolalities and glucose concentrations at 
each time interval during the exchanges are summarised in Table 10
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TABLE 9; CALCULATED AND MEASURED NET ULTRAFILTRATION DURING FOUR HOUR 
EXCHANGES WITH 2 LITRES OF 2.5% DEXTROSE DIALYSIS SOLUTION
CALCULATED NET UF 
(ml)
GROUPS 1 & 2 
(n=18)
GROUP 1 
(n=10)
GROUP 2 
(n=8)
30 min. 261 ± 33 297 ± 36 220 ± 42
60 min. 373 ± 40 393 ± 53 351 ± 63
120 min. 426 ± 50 489 ± 55 354 ± 76
180 min. 389 ± 49 467 ± 60 289 ± 72
240 min. 343 ± 57 474 ± 64 180 ± 71
MEASURED NET UF (ml) GROUPS 1 & 2 GROUP 1 GROUP 2
240 min. 310 ± 58 452 + 54 133 ± 64
Mean ± SEM values in groups 1 and 2 were compared by Student1s 
t test. Measured and calculated net UF at the end of the exchanges 
correlated closely (r=0.96).
< 0.01
< 0.00!
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Cumulative lymphatic absorption, net ultrafiltration 
and cumulative net transcapillary ultrafiltration 
(mean ± SEM) during four hour exchanges in 18 CAPD 
patients using 2 litres of 2.5% dextrose dialysis 
solution.
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Figure 19:
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TABLE 10: DIALYSATE AND SERUM OSMOLALITIES AND GLUCOSE
CONCENTRATIONS DURING FOUR HOUR EXCHANGES WITH 
2 LITRES OF 2.5% DEXTROSE DIALYSIS SOLUTION
OSMOLALITY
(mOsm/L)
GROUPS 1 Sc 2 GROUP 1 GROUP 2
0 min. 358 ± 3 362 ± 4 354 ± 3
D
I 30 min. 335 ± 3 337 ± 4 332 ± 4
A
L 60 min. 324 ± 3 327 ± 6 321 ± 3
Y
S 120 min. 310 ± 4 314 ± 7 304 ± 3
A
T ' 180 min. 302 ± 4 306 ± 8 297 ± 4
E
240 min. 294 ± 4 295 ± 6 294 ± 4
S
E 0 min. 295 ± 4 294 ± 7 297 ± 6
R
U 240 min. 294 ± 4 290 ± 6 300 ± 6
M
GLUCOSE CONCENTRATION 
(mg/dl)
GROUPS 1 & 2 GROUP 1 GROUP 2
0 min. 2140 ± 75 2147 ± 102 2132 ± 110
D 30 min. 1683 ± 59 1709 ± 76 1651 ± 95
I
A 60 min. 1300 ± 53 1367 ± 71 1216 ± 81
L
Y 120 min. 936 ±35 1038 ±42 808 ± 60
S
A 180 min. 690 ± 33 803 ± 40 549 ± 59
T
E 240 min. 535 ± 35 609 ±45 443 ± 61
S
E 0 min. 146 ± 16 172 ± 29 114 ± 14
R
U 240 min. 147 ± 19 164 ± 26 125 ± 29
M
K The mean ± SEM values of groups 1 and 2 were compared 
by Student's t test.
< 0.01  
< 0.005 
<0.05
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and are related to the intraperitoneal volume in Figure 20. The peak 
intraperitoneal volume was observed before the two hour dwell time 
even though osmolar equilibrium did not occur until near the end of 
the exchanges. Glucose dysequilibrium persisted until the end of the 
study dwell time.
GROUPS 1 AND 2
Ultrafiltration kinetics in the patients with average (group 1) 
and high (group 2) peritoneal permeability x area are compared in 
Figure 21 and Tables 8 and 9. Net transcapillary ultrafiltration 
continued throughout the four hour dwell time of exchanges in group 1 
but was virtually complete within the first two hours of the 
exchanges in group 2 (Figure 21). Cumulative net transcapillary 
ultrafiltration at the end of the exchanges was 806 ± 77 ml in group 
1 and 536 ± 92 ml in group 2 (p < 0.05), whereas cumulative lymphatic 
absorption over the four hour dwell time did not differ between the 
two groups (332 ± 65 ml in group 1 and 356 ± 36 ml in group 2) (Table 
8). Thus, although lymphatic absorption was similar in both groups, 
lymphatic drainage caused a proportionately greater reduction in net 
ultrafiltration at the end of the exchanges in group 2 (p < 0.005) 
(Figure 22).
Peak net ultrafiltration was observed earlier in the exchanges 
in group 2 (Figure 21). The net absorption rate after peak 
ultrafiltration was greater in group 2 since lymphatic absorption 
later in the dwell time in these patients was unopposed by
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Figure 20:
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concurrent net transcapillary ultrafiltration (Figure 23). 
Consequently calculated and measured net ultrafiltration volumes 
after the four hour dwell time were significantly lower in group 2 
(Table 9).
Dialysate and serum osmolalities and glucose concentrations 
during the exchanges in group 1 and 2 are compared in Figure 24 and 
Table 10. In group 1 the maximum intraperitoneal volume was observed 
after the two hour dwell time even though osmolar and glucose 
equilibrium did not occur during the four hour exchange (Figure 24). 
In group 2 the peak ultrafiltration volume was observed before the 
two hour dwell time, osmolar equilibrium occurred before the three 
hour dwell time and glucose dysequilibrium continued until the end 
of the exchanges. Thus peak ultrafiltration and osmolar equilibrium 
both occurred earlier in the dwell time in group 2. These data also 
indicate that the maximum intraperitoneal volume was observed before 
net transcapillary ultrafiltration ceased due to dissipation of the 
transperitoneal osmotic gradient and that isosmolality was approached 
before glucose equilibrium.
Rapid absorption of glucose from the dialysate was confirmed in 
the group 2 patients with high peritoneal permeability x area and 
reduced cumulative net transcapillary ultrafiltration (Figure 24). 
Despite the infusion of 2 litres of 2.5% dextrose dialysis solution 
in each exchange, 79 ± 2% of the initial intraperitoneal glucose load 
was absorbed over the four hour dwell time in group 2 compared with 
67 ± 2% in group 1 (p < 0.001). Glucose absorption via the
peritoneal cavity lymphatics did not differ between the two groups
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(3.2 ± 0.4 g in group 2 and 3.6 ± 0.7 g in group 1), even though 41 ± 
2 g of glucose was absorbed from the dialysate during the exchanges 
in group 2 and 34 ± 2 g in group 1. These results confirm that the 
more rapid absorption of glucose from the dialysis solution in group 
2 can be attributed solely to increased transperitoneal absorption 
secondary to high peritoneal permeability x area, and is unrelated to 
the absorption rate via the lymphatics. The importance of the
intraperitoneal glucose concentration in maintaining the
transperitoneal osmotic gradient for ultrafiltration is emphasised by 
the inverse correlation between the percentage of glucose absorbed 
from the dialysis solution over the exchange and both cumulative net 
transcapillary ultrafiltration (r = - 0.54) and measured net
ultrafiltration (r = - 0.69). The serum albumin and glucose
concentrations, serum colloid osmotic pressure, serum osmolality, 
body surface area, duration of CAPD and number of previous episodes 
of peritonitis were similar in both groups (Table 11). Thus the only 
factor which was identified to explain the reduced cumulative net 
transcapillary ultrafiltration in the group 2 patients was their 
higher peritoneal permeability x area (Figures 15,16 & 17), more
rapid transcapillary absorption of dialysate glucose (Figure 24, 
Table 11) and earlier dissipation of the transperitoneal osmotic 
gradient (Figure 24).
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6.3*2 DAILY LYMPHATIC ABSORPTION AND REVERSE SOLUTE CLEARANCES
Extrapolated to four exchanges with 2 litres of 2.5% dextrose
dialysis solution per day, daily lymphatic absorption in the 18 
patients was 2.1 ± 0.2 litres and daily drain volumes were 8.8 ± 0.3 
litres. Thus, lymphatic drainage reduced the potential daily net 
ultrafiltration volume by 82 ± 9% (Figure 25) and the potential daily 
drain volume by 18 ± 2% (Figure 26). Daily lymphatic (reverse) urea
and creatinine clearances were 1.5 ± 0.2 litres and 1.1 ± 0.1 litres, 
respectively and reduced the potential daily urea and creatinine 
clearances by 14.0 ± 1.4% and 13.3 ± 1.5%, respectively (Figure 26).
Daily net ultrafiltration and drain volumes and daily peritoneal 
clearances of urea and creatinine in groups 1 and 2 are compared in 
Table 12. Patients in group 2 had significantly lower daily net 
ultrafiltration (p < 0.005), daily drain volumes (p < 0.005) and
daily urea clearances (p < 0.05). The peritoneal clearances of
creatinine were not significantly different between the two groups 
since the reduced drain volumes in group 2 were compensated for by 
higher dialysate/serum creatinine ratios after the four hour dwell 
time (Figure 16). In contrast dialysate/serum urea ratios approached 
unity at the end of the exchanges in both groups (Figure 15) and the 
peritoneal clearances of urea were related primarily to the daily 
drain volume. The average daily negative ultrafiltration in group 2 
(Figure 25) is consistent with previous clinical observations of 
these patients using four exchanges of 2 litres of 2.5% dextrose
dialysis solution per day (6.2.1).
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6.3.3 EXCHANGES WITH RINGER'S LACTATE SOLUTION WITH ADDED ALBUMIN
Measured net fluid absorption at the end of four hour exchanges 
with 2 litres of near isosmotic Ringer's lactate solution in four of 
the patients was 255 ± 38 ml (Figure 27). The reduction in the
intraperitoneal volume was observed without a significant change in 
the concentration of albumin added to the dialysis solution (Figure 
27). In comparison cumulative lymphatic absorption during the 
previous study exchanges with 2.5% dextrose dialysis solution was 333 
±87 ml in the four patients.
6.3.4 EXCHANGES WITH 2.5% DEXTROSE DIALYSIS SOLUTION WITHOUT ADDED 
ALBUMIN
In the same four patients, measured intraperitoneal volumes 
after two hour exchanges with 2 litres of 2.5% dextrose dialysis 
solution without albumin were 2604 ± 51 ml and calculated
intraperitoneal volumes at the two hour dwell time during exchanges 
with 2 litres of 2.5% dextrose dialysis solution with added albumin 
were 2663 ± 154 ml (r = 0.98). Drain dialysate solute ratios after 
the two hour exchanges with 2.5% dextrose dialysis solution without 
albumin correlated with dialysate solute ratios at the same dwell 
time during the study exchanges with 2.5% dextrose dialysis solution 
and Ringer's lactate with added albumin in these patients (r = 0.75; 
p < 0.05) (Figure 28).
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Moreover, dialysate/serum urea and creatinine ratios and
effluent/initial dialysate glucose ratios during exchanges with 2
litres of 2.5% dextrose dialysis solution without albumin, which were 
performed within the preceding year in 11 of the patients, also 
correlated with dialysate solute ratios during the 2.5% dextrose 
exchanges with added albumin (Figures 29,30 and 31). Net
ultrafiltration (drain + sample volumes - infusion volume) during
these exchanges without albumin averaged 284 ± 107 ml compared with
230 ± 74 ml during the study exchanges with albumin in the same 11
patients (r = 0.66; p < 0.05). These results all suggest that the 
addition of 30 g albumin to 2.5% dextrose dialysis solution did not 
significantly change peritoneal permeability x area or net 
ultrafiltration.
6.4 DISCUSSION
These data indicate that cumulative lymphatic absorption from 
the peritoneal cavity significantly reduces net ultrafiltration and 
solute clearances in CAPD patients. The peritoneal lymphatic 
absorption rates in the 18 CAPD patients in this study averaged 86 ± 
10 ml per hour, which is consistent with prior observations in 
patients with ascites who have no fibrosis or tumour invasion of the 
diaphragmatic and mediastinal lymphatics (128,131-134,148).
This considerable rate of lymphatic absorption has a major 
influence on ultrafiltration kinetics in long-dwell peritoneal 
dialysis (CAPD) exchanges. The maximum intraperitoneal volume occurs
142
Ex
ch
an
ge
s 
wi
th 
Al
bu
m
in
DIALYSATE/SERUM UREA RATIOS
Figure 29:
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Dialysate/serum urea ratios during four hour exchanges 
with 2 litres of 2.5% dextrose dialysis solution with 
added albumin(n=ll) correlated with dialysate solute 
ratios during exchanges with 2 litres of 2.5% dextrose 
dialysis solution without albumin (n=ll) performed 
within the preceding year (r = 0.90).
143
Ex
ch
an
ge
s 
wi
th 
A
lb
um
in
Figure 30:
DIALYSATE/SERUM CREATININE RATIOS
1.0-
0.8-
cPo
0.6-
0.4-
0.2-
r=0.75
0.6 0.80.4 1.00.2
Exchanges without Albumin
Dialysate/serum creatinine ratios during four hour 
exchanges with 2 litres of 2.5% dextrose dialysis 
solution with added albumin are correlated with 
exchanges using 2 litres of 2.5% dextrose dialysis 
solution (n=ll), which were performed within the 
preceding year (r=0.75).
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Figure 31: Effluent/initial dialyate glucose ratios during four
hour exchanges with 2 litres of 2.5% dextrose dialysis 
solution with added albumin are correlated with 
exchanges performed in the same patients (n=ll) within 
the preceding year using 2 litres of 2.5% dextrose 
dialysis solution without albumin (r=0.90).
when the net transcapillary ultrafiltration rate decreases to equal 
the lymphatic absorption rate and the net ultrafiltration rate is 
zero (Figure 19). Consequently peak net ultrafiltration is observed 
during CAPD exchanges while net transcapillary ultrafiltration 
continues and before osmolar equilibrium between serum and dialysate 
is reached (Figures 19 & 20). Thereafter, the lymphatic absorption
rate exceeds the net transcapillary ultrafiltration rate and the 
intraperitoneal volume decreases. Thus the net absorption rate 
after maximum intraperitoneal volume represents lymphatic absorption 
minus concurrent net transcapillary ultrafiltration (Figures 19 & 
23). Osmolar equilibrium precedes glucose equilibrium during CAPD 
exchanges (Figures 20 & 24) because of solute sieving with
ultrafiltration. These findings are similar to the kinetics of 
ultrafiltration during exchanges with hypertonic dextrose dialysis 
solution in rats (5.3.1). The calculated net fluid absorption rates 
in this study (Figure 19) are in agreement with previous sequential, 
direct measurements of drain volumes in CAPD patients (25,26) and 
infer that fluid absorption in CAPD is mainly via the peritoneal 
cavity lymphatics.
The peritoneal lymphatic absorption rates reported herein are 
higher than in a previous study of CAPD patients (156). However, 
peritoneal lymphatic flow rates in the prior study were
underestimated since lymphatic absorption was calculated from the 
mass transfer rate of radio-iodinated serum albumin from the 
peritoneal cavity to the blood (4.4.1). Lymphatic absorption in the 
present study was estimated from the rate of removal of
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intraperitoneal albumin from the peritoneal cavity (4.4.2) and thus 
it was important to exclude the presence of extraperitoneal 
dialysate leaks in the study patients. None of the patients had 
clinical evidence of an external dialysate leak, and three of the 
patients with poor peritoneal ultrafiltration and clinical suspicion 
of an internal dialysate leak had negative studies after 
intraperitoneal infusion of radio-contrast (177).
Two findings in this study suggest that there was no significant 
adsorption of the administered albumin to the mesothelium of the 
peritoneal membrane. Firstly, only 1.8 ± 0.4 g of albumin was
removed in the post-study in and out exchange, which can be accounted 
for by the albumin content of the study residual volume. Secondly, 
the albumin concentration remained constant during absorption of 
isotonic intraperitoneal fluid in four of the patients (Figure 27). 
The exchanges with 2.5% dextrose dialysis solution without added 
albumin show that the addition of 30 g albumin had no significant 
effect on peritoneal permeability x area or net ultrafiltration 
(Figures 28-31). The validity of the calculations is also supported 
by the close correlation between measured and calculated 
intraperitoneal volumes at the two hour dwell time in four of the 
patients (r = 0.96) and measured and calculated net ultrafiltration 
at the end of the four hour exchanges in all of the patients (r =
0.97).
The lymphatic absorption rates in the patients with average and 
high peritoneal permeability x area did not differ. However, 
lymphatic absorption causes a proportionately greater reduction in
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net ultrafiltration in patients with high peritoneal permeability x 
area (Table 8) since these patients have more rapid absorption of 
glucose from the dialysis solution (Figure 24), earlier dissipation 
of the transperitoneal osmolar gradient and lower cumulative net 
transcapillary ultrafiltration (Figure 21). Extrapolated to four 
exchanges with 2 litres of 2.5% dextrose dialysis solution per day, 
the group 2 patients with high peritoneal permeability x area had 
negative daily ultrafiltration even though daily net transcapillary 
ultrafiltration averaged 2.1 ± 0.4 litres (Figure 25). Thus, in the 
absence of a dialysate leak, loss of peritoneal ultrafiltration in 
CAPD patients occurs when daily lymphatic absorption equals or 
exceeds daily net transcapillary ultrafiltration.
Lymphatic absorption rates in this study may be higher than in 
active CAPD patients since the exchanges were all performed in the 
supine position and fluid contact with the diaphragm may have been 
more extensive than in the upright posture (108). Alternatively, the 
increase in intraperitoneal pressure with upright posture (36,178) 
may tend to increase lymphatic absorption in active CAPD patients 
(112). Further studies are needed to compare lymphatic absorption 
rates in the supine and upright positions. The lymphatic absorption 
rates of the CAPD patients in this study were unrelated to the number 
of prior episodes of peritonitis. This suggests that CAPD associated 
peritonitis has no long-term effect on the patency or function of the 
peritoneal cavity lymphatics. None of the patients were studied 
within three months of peritonitis since acute peritonitis may alter 
the lymphatic absorption rate (118). However, the influence of CAPD
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associated peritonitis on lymphatic absorption has still to be 
evaluated.
Although the physiological role of the peritoneal lymphatics in 
maintaining a small volume of isosmotic fluid in the peritoneal 
cavity and improving host defences is advantageous, lymphatic 
absorption has adverse sequelae in all CAPD patients. Net 
ultrafiltration with four exchanges of 2 litres of 2.5% dextrose 
dialysis solution per day averaged only 18% of daily cumulative net 
transcapillary ultrafiltration (Figure 25) and daily reverse 
(lymphatic) solute clearances reduced daily peritoneal clearances of 
urea and creatinine by greater than 13% (Figure 26). Thus, previous 
estimates of peritoneal mass transfer, which were based on dialysate 
drain volumes and solute concentrations and neglected translymphatic 
transport during the dwell time, are erroneously low (57-59,64-66). 
Consequently net ultrafiltration and solute clearances in CAPD may 
be increased if daily lymphatic drainage is reduced. Pharmacological 
reduction of lymphatic absorption would alleviate the problem of loss 
of ultrafiltration observed in some CAPD patients and may provide a 
means for future improvement in the efficiency of CAPD.
6.5 CONCLUSIONS
1. Lymphatic absorption in CAPD is considerable and averages 86 ±
10 ml per hour during exchanges with 2 litres of 2.5% dextrose
dialysis solution.
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2. Peak net ultrafiltration is observed during CAPD exchanges 
before net transcapillary ultrafiltration ceases due to 
dissipation of the transperitoneal osmotic gradient.
3. The net absorption rate after peak intraperitoneal volume 
represents the lymphatic absorption rate minus the concurrent 
net transcapillary ultrafiltration rate.
4. Cumulative lymphatic absorption significantly reduces net 
ultrafiltration and solute clearances after four hour exchanges 
in all CAPD patients.
5. Cumulative lymphatic absorption causes a proportionately greater 
reduction in net ultrafiltration in patients with high 
peritoneal permeability x area since these patients have more 
rapid absorption of glucose from the dialysis solution, earlier 
dissipation of the transperitoneal osmotic gradient during the 
dwell time and less cumulative net transcapillary 
ultrafiltration.
6. Failure of peritoneal ultrafiltration occurs in CAPD patients 
when daily lymphatic absorption equals or exceeds daily net 
transcapillary ultrafiltration.
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Chapter 7 LYMPHATIC ABSORPTION IN CHILDREN ON PERITONEAL DIALYSIS
7.1 INTRODUCTION
Peritoneal dialysis has several advantages over haemodialysis in 
the treatment of children with azotaemia and thus has become the 
preferred dialytic modality for most children developing end-stage 
renal disease (179,180). Previous studies of ultrafiltration
kinetics in CAPD suggest that net ultrafiltration, scaled for body 
surface area, is lower in children than in adults (181-183). The 
relative reduction in net ultrafiltration volumes in children on CAPD 
has been attributed to more rapid absorption of glucose from the 
dialysis solution and earlier dissipation of the transperitoneal 
osmotic gradient (181,182). However, in a paediatric CAPD 
population with poor ultrafiltration capacity, net ultrafiltration 
did not correlate with the duration of CAPD, the patient's age at the 
onset of dialysis, the occurrence of prior episodes of peritonitis or 
the use of 4.25% dextrose or acetate containing dialysis solutions 
(184). Thus, as in adults, the pathophysiology of the loss of 
peritoneal ultrafiltration capacity in children on long-dwell
peritoneal dialysis remains incompletely understood.
Intraperitoneal blood transfusions have been performed in
children for over fifty years (185-187). Following intraperitoneal 
infusion red blood cells are absorbed intact by the peritoneal cavity 
lymphatics at a rate only slightly lower than intraperitoneal plasma 
(78,86). Lymphatic absorption from the peritoneal cavity may also
151
significantly reduce net ultrafiltration during long-dwell peritoneal 
dialysis exchanges in children. This study was performed to evaluate 
the contribution of cumulative lymphatic absorption during the dwell 
time to the loss of ultrafiltration and solute clearances in children 
on peritoneal dialysis.
7.2 PATIENTS AND METHODS
7.2.1 PATIENTS
Standardised four hour exchanges using 2.5% dextrose dialysis 
solution were performed in 6 children on CAPD or CCPD (continuous 
cyclic peritoneal dialysis) (188). The study was approved by the 
Institutional Review Board for Human Experimentation, University of 
Missouri-Columbia and the parents of each child gave written, 
informed consent. At the time of study, the mean age of the children 
was 9 ± 2  (SEM) years (range 2-13) and the mean duration of CAPD was
19 ± 6 months (range 10-47). None of the children had clinical
evidence of dialysate leaks or fluid overload. Although all of the 
children had had at least one prior episode of peritonitis (mean 2.3 
± 2.0 episodes), none had peritonitis within three months of the
study. All of the patients had always used lactate containing 
dialysis solutions and none of the children had clinical or
biochemical features of acute or chronic liver disease. The clinical
data of each patient at the time of study are summarised in Table 13.
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7.2.2 STUDY EXCHANGES
Each study was performed after a four hour exchange using the 
child's usual infusion volume (Table 13) of 2.5% dextrose dialysis 
solution (Dianeal PD-2). To standardise the dialysis mechanics of 
the study exchanges and thereby permit interpatient comparisons, the 
study infusion volume was 40 ml/Kg body weight for each child. The
study dialysis solution was prepared by preheating 1.0 or 1.5 litres
of 2.5% Dianeal PD-2 to 37° C, removing the required volume of 
dialysate with aseptic technique and adding 25% human serum albumin 
(Baxter-Travenol, Deerfield, Illinois) to give a volume of 1.5% 
albumin dialysis solution equivalent to 40 ml/Kg body weight. The 
standardised study volumes were selected to correspond to infusion 
volumes routinely used in children on CAPD (179,180). The protocol 
for the study exchanges was thereafter the same as described 
previously for the adult CAPD patients (6.2.2). It is emphasised
that all the dialysate samples were taken with strict aseptic
technique using a povidone-iodine solution impregnated sponge 
(Connection Shield III, Baxter-Travenol, Deerfield, Illinois) over 
the sample port of the dialysis bag. Fortunately these precautions 
proved to be adequate since none of the patients (adults as well as 
children) developed peritonitis within one week of undergoing the 
study exchange. The laboratory methods, calculations and statistical 
analysis were the same as in Chapter 6.
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7.3 RESULTS
7.3.1 EXCHANGES WITH 2.5% DEXTROSE DIALYSIS SOLUTION IN CHILDREN
Mean cumulative lymphatic absorption from the peritoneal cavity 
during four hour exchanges with AO ml/kg of 2.5% dextrose dialysis 
solution averaged 257 ± 67 (SEM) ml in the six children. To enable
the analysis of group data from exchanges with variable infusion 
volumes, cumulative net transcapillary ultrafiltration, lymphatic 
absorption and calculated net ultrafiltration during the exchanges in 
children are expressed in Figure 32 as a percentage of the 
intraperitoneal volume at the beginning of each exchange. Net 
transcapillary ultrafiltration occurred mainly during the first two 
hours of the dwell time, whereas lymphatic absorption continued at a 
linear rate throughout the exchanges. Thus, peak ultrafiltration was 
observed at around the 90 minutes dwell time (Figure 32) and at the 
end of the exchanges calculated net ultrafiltration averaged only 27 
± 10% of total net transcapillary ultrafiltration during the exchange 
(Table 1A). Calculated net ultrafiltration correlated closely with 
measured ultrafiltration at the end of the four hour dwell time (r =
0.9A; p < 0.02) (Table 1A). Maximum intraperitoneal volume,
expressed as a percentage of the initial intraperitoneal volume, 
preceded osmolar equilibrium which in turn preceded the approach of 
glucose equilibrium (Figure 33).
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Figure 32: Cumulative net transcapillary ultrafiltration,
lymphatic absorption and net ultrafiltration (mean ± 
SEM) during four hour exchanges in children using 40 
ml/Kg of 2.5% dextrose dialysis solution. All values 
are expressed as a percentage of the intraperitoneal 
volume at the beginning of the exchange (IPVQ).
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TABLE 14: ULTRAFILTRATION KINETICS IN CHILDREN AFTER FOUR HOUR EXCHANGES 
WITH 2.5% DEXTROSE DIALYSIS SOLUTION*
FLUID TRANSPORT 
(after 4 hrs)
ABSOLUTE VOLUMES 
(ml)
ABSOLUTE VOLUMES/INITIAL 
INTRAPERITONEAL VOLUME (%)
Net Transcapillary UF 383 ± 88 31 ± 4
Lymphatic Absorption 257 ± 67 20 ± 3
Calculated Net UF 125 ± 54 10 ± 4
Measured Net UF 104 ± 55 8 ± 4
* Infusion volumes of dialysis solution were 40 ml/Kg for each 
exchange and accordingly results (mean ± SEM) are also expressed as a 
percentage of the intraperitoneal volume at the beginning of the exchanges.
157
F ig u re  33:
« 1201 © o
o t  
© ©
= 1 h°H
n
100H
A
— ©Dialysate 
— 0  Serum
/ V
-c
3 360- \
E
v>
O
f  320
o
E
g  2801
Osmolar
EquilibriumI
2500-
O)
© 1500-
500-
1 2 30 4
Dwell Time (Hours)
Intraperitoneal volume, dialysate and serum 
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7,3*2 COMPARISON OF ULTRAFILTRATION KINETICS IN CHILDREN AND ADULTS
Cumulative lymphatic absorption after four hour exchanges with 
2.5% dextrose dialysis solution in children and in adults with 
average peritoneal permeability x area (group 1 from Chapter 6) are 
compared in Table 15. For valid comparisons the absolute lymphatic 
absorption rates in each group are expressed in relation to body 
weight, body surface area, intraperitoneal volume and dialysate 
glucose load. Lymphatic absorption was higher in children than in 
adults but the difference only reached significance when corrected 
for body weight (p < 0.01; Table 15).
Cumulative net transcapillary and measured net ultrafiltration 
volumes after the four hour exchanges in children and adults are 
compared in Table 16. Cumulative net transcapillary ultrafiltration 
tended to be lower in children when adjusted for body surface area, 
intraperitoneal volume or dialysate glucose load but was higher when 
expressed relative to body weight (Table 16). Consequently the 
proportion of total net transcapillary ultrafiltration reabsorbed by 
the peritoneal cavity lymphatics was greater during the exchanges in 
children (73 ± 10%) than in adults (40 ± 6%; p < 0.01). Measured net
ultrafiltration, scaled for body surface area, intraperitoneal volume 
and dialysate glucose load, was significantly lower in children 
(Table 16).
The kinetics of ultrafiltration during the exchanges in the 
children in this study were similar to adult CAPD patients with high 
peritoneal permeability x area (group 2 from Chapter 6). Firstly,
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TABLE 15: LYMPHATIC ABSORPTION AFTER FOUR HOUR EXCHANGES IN
CHILDREN AND ADULTS RELATED TO BODY WEIGHT, BODY SURFACE 
AREA, INTRAPERITONEAL VOLUME AND DIALYSATE GLUCOSE LOAD.
LYMPHATIC ABSORPTION CHILDREN ADULTS
*
ml/Kg body weight 10.3 ± 1.8 A.A ± 0.9 p < 0.01
ml/m^ body surface area 271 ± A8 180 ±36
% initial intraperitoneal volume* 20.A ± 3.0 13.9 ± 2.7
ml/g dialysate glucose load 8.9 ± 1.7 6.9 ± 1.5
* Mean ± SEM values were compared by Student's t test.
* The infusion volumes averaged 26 ml/Kg (1254 ± 63 ml/m^ 
body surface area) in adults and AO ml/Kg (1333 ± 156 ml/m^) 
in children.
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TABLE 16: ULTRAFILTRATION VOLUMES IN CHILDREN AND ADULTS RELATED
TO BODY WEIGHT, BODY SURFACE AREA, INTRAPERITONEAL 
VOLUME AND DIALYSATE GLUCOSE LOAD.
NET TRANSCAPILLARY UF CHILDREN ADULTS *
ml/Kg body weight 15.4 ± 2.1 10.6 ± 1.2 p < 0.05
ml/m^ body surface area 406 ±61 430 ± 42
% initial intraperitoneal volume 31 ± 4 34 ± 2.9
ml/g dialysate glucose load 13.4 ± 2.0 16.1 ± 1.8
MEASURED NET UF CHILDREN ADULTS
ml/Kg body weight 4.1 ± 1.9 5.9 ± 0.7
ml/m^ body surface area 111 ± 52 237 ± 26 p < 0.05
% initial intraperitoneal volume 9.2 ± 3.8 19.1 ± 2.2 p < 0.05
ml/g dialysate glucose load 3.5 ± 1.9 8.8 ± 1.6 p < 0.01
A Mean ± SEM values compared by Student's t test.
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the rate of absorption of dialysate glucose and the rate of 
equilibration of dialysate and serum urea were significantly above 
the reference range in adults (Figures 34 and 35, respectively). 
Secondly, peak ultrafiltration and osmolar equilibrium during the 
exchanges in this group of children were observed as early in the 
dwell time (Figure 33) as during the exchanges in adults with high 
peritoneal permeability x area (Figure 24). Thirdly, the percentage 
of the dialysate glucose load absorbed during the exchanges in 
children (79 ± 6%) was higher than in exchanges in adults with 
average peritoneal permeability x area (67 ± 2%; p < 0.025). Despite 
the differences in peritoneal transport rates, the duration of 
peritoneal dialysis and the number of prior episodes of peritonitis 
did not differ significantly between the children and adults with 
average peritoneal permeability x area.
7.3.3 DAILY LYMPHATIC ABSORPTION AND REVERSE SOLUTE CLEARANCES
Extrapolated to four exchanges with 40 ml/Kg of 2.5% dextrose 
dialysis solution per day, the daily drain volume in the children 
averaged 168 ± 15 ml/Kg while daily lymphatic absorption was 62 ± 11
ml/Kg (Figure 36). Thus lymphatic absorption produced a
proportionately greater reduction in the potential daily drain volume 
in peritoneal dialysis in children (27 ± 5%) than in adults with
average peritoneal permeability x area (16 ± 3% ; p < 0.05).
Daily peritoneal and reverse (lymphatic) clearances of urea and 
creatinine, scaled for body weight, are shown in Figure 36. Lymphatic
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absorption reduced the daily potential clearances of urea and
creatinine in the children by 24 ± 4% and 22 ±5%, respectively.
Daily urea and creatinine clearances in children and adults with 
average peritoneal permeability x area are compared in Table 17.
Peritoneal and reverse solute clearances, corrected for body weight, 
were significantly higher in children than in adults. However, when 
related to body surface area, urea and creatinine clearances in 
children (4.2 ± 0.4 and 3.5 ± 0.2 L/m^/day, respectively) were not
significantly different from peritoneal clearances of urea and
creatinine in adults (4.9 ± 0.3 and 4.1 ± 0.3 L/m^/day,
respectively). Nevertheless, the reduction in daily potential solute 
clearances due to lymphatic absorption was significantly higher in 
children than in adults (Table 17).
7.4 DISCUSSION
This study indicates that cumulative lymphatic absorption from 
the peritoneal cavity significantly reduces net ultrafiltration and 
solute clearances in children on peritoneal dialysis. The kinetics 
of peritoneal dialysis in children of diverse body size can only be 
interpreted meaningfully if the dwell time, osmolality and volume of 
exchanges are standardised (179,189). The dialysis mechanics of the 
study exchanges in this group of children were kept constant and 
infusion volumes of 40 ml/Kg were selected to simulate exchange 
volumes used routinely in CAPD or CCPD in children (179,180,189). 
Consequently group data in the children were analysed in relation to
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TABLE 17: PERITONEAL AND REVERSE SOLUTE CLEARANCES IN CHILDREN AND
ADULTS USING FOUR EXCHANGES WITH 2.5% DEXTROSE DIALYSIS 
SOLUTION PER DAY.
SOLUTE CLEARANCES CHILDREN ADULTS
Peritoneal urea clearances (ml/Kg/day) 158 ± 20 121 ± 9 P < 0.05
Reverse urea clearance (ml/Kg/day) 50 ± 11 17 ± 3 P < 0.005
Reverse/potential urea clearance (%) 24 ± 4 12 ± 2 P < 0.01
Peritoneal creatinine clearance (ml/Kg/day) 133 ± 13 104 ± 12
Reverse creatinine clearance (ml/Kg/day) 39 ± 10 13 ± 2 P < 0.005
Reverse/potential creatinine clearance (%) 22 ± 5 11 ± 2 P < 0.05
5< Mean ± SEM solute clearances or clearance ratios were 
compared by Student's t test.
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intraperitoneal volume or body weight (Figures 32 & 33, Tables 14- 
17).
Lymphatic absorption during the four hour exchanges in the 
children averaged 2.6 ± 0.4 ml/Kg per hour. This considerable rate
of lymphatic drainage resulted in the peak intraperitoneal volume 
being observed well in advance of osmolar equilibrium (Figure 33). 
Although osmolar equilibrium occurred at the three hours dwell time, 
glucose dysequilibrium continued until the end of the exchanges 
(Figure 33). Similar findings were observed during exchanges in 
adults on CAPD (Figures 18 and 20).
The kinetics of peritoneal dialysis in children and adults were 
compared during four hour exchanges with 2.5% dextrose dialysis 
solution. The dialysis mechanics of the exchanges were the same 
except for the infusion volumes of dialysis solution, which in adults 
averaged 26 ml/Kg and in children were standardised at 40 ml/Kg. 
These infusion volumes, however, are similar to exchange volumes used 
clinically in both adults and children. Thus scaled comparisons will 
reflect differences in ultrafiltration and solute kinetics during 
standard peritoneal dialysis exchanges in children and adults.
Measured net ultrafiltration at the end of four hour exchanges 
is lower in children than adults with average peritoneal permeability 
x area, when scaled for body surface area (183), initial 
intraperitoneal volume or dialysate glucose load (Table 16). When 
adjusted for the same parameters, lymphatic absorption during the 
exchanges in children tended to be higher and net transcapillary 
ultrafiltration lower than in adults (Tables 15 & 16). Thus, since
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net ultrafiltration equals cumulative net transcapillary 
ultrafiltration minus lymphatic absorption, the above combination of 
factors most likely explains the relatively low measured net 
ultrafiltration in children. However, this relatively low net
ultrafiltration capacity in children is compensated to some extent by 
the routine use of higher infusion volumes (ml/Kg). In effect net 
ultrafiltration volumes in children and adults are equal when 
corrected for body weight,' but are achieved at the expense of a 
relatively higher intraperitoneal volume, higher dialysate glucose
load and higher transperitoneal glucose absorption. Impaired calorie 
intake and poor growth rates are major problems in uraemic children 
and the high obligatory dialysate glucose (and calorie) load per Kg 
in children may not produce metabolic complications as frequently as 
in adults (31).
Net transcapillary ultrafiltration and solute kinetics in the 
studied children were similar to adults with high peritoneal 
permeability x area. Glucose was absorbed rapidly from the dialysis 
solution (Figure 34) (181-183) and peak ultrafiltration and osmolar
equilibrium occurred early in the dwell time (Figure 33). Likewise
the rate of equilibration of dialysate and serum urea was also more 
rapid in children than adults with average peritoneal permeability x 
area (Figure 35) (183). These findings occurred despite higher
infusion volumes per Kg body weight in children, which would tend to 
delay peritoneal solute transport by reducing peritoneal surface area 
to volume relationships (33,56). Thus the higher transperitoneal 
solute transport rates in the children cannot be attributed to, and
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indeed should be lessened by, differences in dialysis mechanics 
between the children and adults. The apparently higher peritoneal
permeability x area in children may be related to their higher 
peritoneal surface area/body weight ratio and presumably higher
functional membrane transfer area/body weight ratio (14).
Peritoneal solute clearances, scaled for body weight, are higher 
in children than adults (Table 17). The augmented peritoneal 
clearances (ml/Kg/day) in children, however, are due to the routine
use of higher dialysate volumes (ml/Kg) as well as the more rapid 
equilibration of small solutes. These factors may explain the
success of CCPD, with three or four overnight exchanges and one
daytime exchange, in maintaining adequate daily peritoneal solute 
clearances in most children (188). Moreover, with long-dwell CAPD
exchanges in children, the rapid absorption of glucose from the
dialysate, early dissipation of the transperitoneal osmolar gradient 
and early onset of net fluid absorption may result in inadequate 
daily net ultrafiltration. The kinetics of peritoneal dialysis in 
children may be more suited to short-dwell intermittent dialysis 
therapy such as nightly peritoneal dialysis (175). This form of 
peritoneal dialysis also allows the child freedom from daytime 
exchanges.
Lymphatic absorption during peritoneal dialysis in children 
causes a proportionately greater reduction in daily net
ultrafiltration and solute clearances than in adults. Thus, the 
efficiency of peritoneal dialysis may be increased to a greater
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extent in children than in adults if lymphatic absorption is
reduced.
7.5 CONCLUSIONS
1. Lymphatic absorption significantly reduces net ultrafiltration
and solute clearances in children on long-dwell peritoneal 
dialysis exchanges.
2. Net ultrafiltration volumes, scaled for body surface area,
dialysate glucose load or intraperitoneal volume, are lower in 
children than adults due to a combination of relatively higher 
lymphatic absorption and lower net transcapillary 
ultrafiltration.
3. Lymphatic absorption produces a relatively greater reduction in
solute clearances in children than in adults.
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Chapter 8. EFFECT OF PERITONITIS ON ABSORPTION OF INSULIN AND
GLUCOSE DURING PERITONEAL DIALYSIS IN DIABETIC RATS
8.1 INTRODUCTION
Diabetic nephropathy is a major and ever increasing cause of 
renal failure in patients beginning renal replacement therapy (9). 
CAPD rather than haemodialysis is often advocated for diabetic 
patients beginning dialysis since CAPD avoids the need for vascular 
access or systemic heparinisation, maintains steady state metabolite 
concentrations, can provide continuous control of fluid status and 
hypertension without inducing haemodynamic instability, and may 
retard the progression of neuropathy (190,191). Furthermore, despite 
the additional glucose load absorbed from the dialysis solution, 
glycaemic control in diabetic dialysis patients can be improved by 
the intraperitoneal administration of insulin with each CAPD exchange 
(191-194). In the USA more than one quarter of all patients now 
beginning CAPD have end-stage renal disease secondary to diabetic 
nephropathy (10).
Bacterial peritonitis continues to be the most frequent 
complication of CAPD therapy (163). The dosage of intraperitoneal 
insulin required for glycaemic control in diabetic CAPD patients may 
change during episodes of peritonitis. Increased absorption of 
glucose from the dialysis solution (44,195,196), insulin resistance 
secondary to infection and physical inactivity during acute illness 
will tend to increase insulin requirements during peritonitis.
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Alternatively, insulin demands may decrease if insulin absorption 
across the inflamed peritoneum and via the peritoneal cavity 
lymphatics increases or if oral carbohydrate intake is reduced. 
Although intraperitoneal insulin requirements are widely believed to 
increase during CAPD associated peritonitis (163,197), symptomatic 
hypoglycaemia has been observed in diabetic CAPD patients when the 
usual dosage of intraperitoneal insulin was continued during 
peritonitis (198).
The relative absorption rates of glucose and insulin during 
peritonitis in diabetic CAPD patients have not been studied. Insulin 
administered into the peritoneal cavity enters the portal venous 
circulation by diffusion across the visceral peritoneum and the 
capsule of the liver (199,200), and also reaches the systemic 
circulation directly by diffusion across the parietal peritoneum and 
by convective transport via the peritoneal cavity lymphatics (201). 
This study was performed to evaluate lymphatic and transperitoneal 
absorption of insulin and glucose during peritoneal dialysis in 
diabetic rats with and without peritonitis.
8.2 MATERIALS AND METHODS
8.2.1 ANIMAL MODEL
Diabetes mellitus was induced in 250-300g, male Sprague-Dawley 
rats by injecting streptozocin (Sigma Chemical Co., St. Louis, 
Missouri) 65 mg/Kg into the tail vein under ether anaesthesia (202).
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Streptozocin is a listed carcinogen in the Federal Hazardous Waste 
Guide and therefore all materials used in the injection of 
streptozocin were double bagged and labelled with a biohazard warning 
prior to incineration. After recovering from anaesthesia, the 
animals were placed in metabolic cages and fed standard rat chow 
(Purina Ralston Co., St. Louis, Missouri) and water ad libitum for 
one week. Weight, food and water intake and urine output were 
recorded daily.
8.2.2 STUDY PROTOCOL
Seven days after streptozocin injection, six of the rats were 
anaesthetised with ether and inoculated with 1 ml Heart Brain 
suspension containing 10^ colony forming units/ml Staphylococcus 
epidermidis. The other six diabetic rats acted as controls. The 
study exchanges were performed the next morning. Overnight the rats 
were allowed free access to water only. Following subcutaneous 
injection of 50 mg/Kg pentobarbital sodium (Nembutal, Abbott 
Laboratories, North Chicago, Illinois), an external jugular venous 
catheter was inserted for infusion of intravenous fluids. A femoral 
arterial catheter (Intramedic polyethylene tubing, Clay Adams, 
Parsippany, New Jersey) was placed to monitor blood pressure and to 
permit serial blood sampling. Blood pressure was monitored using a 
P32/D pressure transducer (Gould Stratham, Hato Rey, Puerto Rico) 
connected to a Model 7 polygraph (Grass Instruments Co., Quincy, 
Massachusetts). The peritoneal dialysis catheter was inserted
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through a mid-line incision as described previously (5.2.1). All 
rats were hydrated with Ringer's lactate solution until voiding 
urine. Immediately before the study exchange, an in and out exchange 
was performed with 15 ml of 2.5% dextrose dialysis solution to 
estimate the intraperitoneal residual volume. White blood cell count 
(WBC/mm^) and culture were performed on the washout dialysate to 
document the presence of infection in the peritonitis group (group 
1) and exclude infection in the control rats (group 2).
Albumin (25% human serum albumin, Baxter-Travenol, Deerfield, 
Illinois) was added to 2.5% dextrose dialysis solution (Dianeal PD-2) 
to give a 2.5% albumin study dialysis solution. Two hour peritoneal 
dialysis exchanges were performed in all rats using 25 U regular 
insulin (Humulin, Eli Lilly Co., Indianapolis, Indiana) added to 15 
ml of the study dialysis solution. Serial dialysate samples (0.5 ml) 
were obtained at baseline and time 0, 20, 60, 90 and 120 minutes
after infusion. To obtain each dialysate sample, 1 ml of dialysis 
solution was aspirated into a sterile syringe to clear the catheter 
dead space, the sample taken, and then the aspirated dialysate 
reinfused. Serial blood samples (0.5 ml) were also taken at the same 
time intervals. Ringer's lactate solution was infused throughout the 
exchange using a syringe pump (Sage Instruments, model 341) to 
replace ultrafiltration and blood sample losses. Insulin, glucose 
and albumin concentrations were measured in all dialysate and serum 
samples. The haematocrit was also measured in each blood sample. 
Extra blood (1.2 ml) was taken at the beginning and end of the two 
hour exchanges to measure plasma C-peptide concentrations. At the
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end of two hours, the dialysate solution was drained completely and 
measured in a graduated cylinder. Similar two hour exchanges using
15 ml of 2.5% dextrose dialysis solution without added albumin were 
also performed in five rats with peritonitis and five rats without 
peritonitis.
8.2.3 LABORATORY METHODS
Serum and dialysate glucose concentrations were measured by the 
glucose oxidase method using a YSI model 27 glucose analyser (Yellow 
Springs Instrument Co. Inc., Ohio). Serum and dialysate
immunoreactive insulin (IRI) were measured by the coated charcoal
radioimmunoassay (203). Plasma C-peptide concentrations were 
measured by a double antibody radioimmunoassay (Diagnostic Products 
Corporation, Los Angeles, California). Bacterial cultures of the
dialysate were performed on blood agar. Dialysate albumin 
concentrations were determined by the bromcresol method (5.2.4).
8.2.4 CALCULATIONS
The intraperitoneal volume at the beginning and end of the study 
exchanges was calculated as the residual volume, measured from the 
prior in and out exchange, plus the infusion and drain volume, 
respectively. Net ultrafiltration was measured as drain volume minus 
infusion volume. Cumulative lymphatic absorption and net
transcapillary ultrafiltration during the exchanges were calculated
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as described previously (5.2.5 and 6.2.4). The drain dialysate 
albumin concentration was corrected for the influx of albumin during 
the dwell time by subtracting the mean drain dialysate albumin 
concentration of the corresponding group of rats without addition of 
albumin to the infused dialysis solution.
The percentages of glucose, insulin and albumin absorbed from 
the dialysis solution were calculated as:
(V2 x C2) + (Vs x E Cs)
( 1 -   ) x 100%
(VQ X c0)
where V2 and Vq = intraperitoneal volumes at times 0 and 2
hours, respectively 
C2 and Cg = solute concentrations at times 0 and 2 hours
Vs = sample volume (0.5 ml)
E Cs = sum of solute concentrations in samples at
times 0, 20, 60 and 90 mins
Results in groups 1 and 2 were compared by Student’s non-paired 
and paired t test where appropriate.
8.3 RESULTS
Polyuria, polydipsia and weight loss were observed in all of the 
rats during the week following streptozocin injection (Table 18). 
Diabetes mellitus was confirmed in each rat by performing fasting
TABLE 18; FLUID BALANCE AND BODY WEIGHT OF RATS FOLLOWING 
STREPTOZQCIN INJECTION
RAT GROUP GROUP 1 GROUP 2 CONTROL
Water Intake (ml/day) 
Day 1 
Day 7
69 ± 8 
150 ± 11
59 ± 6 
150 ± 20
43 ± 2 
34 ± 1
Urine Output (ml/day) 
Day 1 
Day 7
47 ± 6 
97 ± 9
32 ± 6 
95 ± 19
4 ± 3 
4 ± 3
Weight Change (g) 
Days 1-7 -24 ± 5 -14 ± 4 +11 ± 6
Daily water intake and urine output (mean ± SEM) in 
diabetic rats during days 2-6 following streptozocin 
injection were intermediate to volumes observed on days 1 
and 7.
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blood glucose concentrations on the morning of the study (Table 19). 
The immediate in and out exchange in the group 1 rats yielded cloudy 
drain dialysate, which contained greater than 500 WBC/mm^ and gave 
positive culture results. There was no evidence of peritonitis in 
the group 2 rats.
The drain and net ultrafiltration volumes after the two hour 
study exchanges were lower in the rats with peritonitis. Net 
ultrafiltration in group 1 averaged 1.4 ± 1.3 (SEM) ml compared with
3.3 ± 0.5 ml in group 2. Serial dialysate glucose and insulin
concentrations in both groups of rats are depicted in Figure 37. 
Despite lower net ultrafiltration, dialysate glucose and insulin
concentrations both decreased more rapidly in the rats with 
peritonitis. However, only the differences in dialysate glucose 
concentrations were statistically significant (p < 0.05) (Figure 37).
Glycaemic control was similar during the exchanges in both 
groups of rats even though serum insulin levels tended to be higher
in group 1 (Table 19). This may be explained, at least in part, by
the higher absorption of glucose from the dialysate in group 1 
(Figure 37). Plasma C-peptide levels were low at the beginning and 
end of the exchanges in both groups, indicating that endogenous 
insulin secretion was minimal in spite of the presence of 
hyperglycaemia (Table 19).
Cumulative lymphatic absorption was higher during the exchanges 
in rats with peritonitis (7.8 ± 1.1 ml in group 1 and 5.9 ± 0.7 ml in 
group 2 ; 0.05 < p < 0.1). Total net transcapillary ultrafiltration
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TABLE 19: SERUM INSULIN AND GLUCOSE AND PLASMA C-PEPTIDE
CONCENTRATIONS DURING 2 HOUR EXCHANGES IN DIABETIC 
RATS WITH AND WITHOUT PERITONITIS
SERUM GLUCOSE 
(mg/dl)
GROUP 1 GROUP 2
0 323 ± 25 327 ± 27
20 322 ± 29 316 ± 33
60 212 ± 32 250 ± 44
90 174 ± 37 223 ± 51
120 163 ± 26 206 ± 56
SERUM INSULIN 
(liU/ML)
GROUP 1 GROUP 2
0 41 ± 12 26 ± 6
20 1808 ± 498 1048 ± 258
60 2936 ± 990 1944 ± 750
90 6384 ± 2717 4867 ± 1943
120 7720 ± 2630 7167 ± 868
PLASMA C-PEPTIDE GROUP 1 GROUP 2
(ng/ml)
0 0.21 ± 0.02 0.23 ± 0.02
120 0.22 ± 0.01 0.26 ± 0.01
All values are expressed as mean ± SEM.
Normal range of plasma C-peptide levels in rats is
0.8 - 4.0 ng/ml. Values in diabetic rats are < 0.5 ng/ml.
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Figure 37: Dialysate insulin and glucose concentrations (mean ±
SEM) during 2 hour exchanges using 15 ml, 2.5% 
dextrose dialysis solution in diabetic rats with and 
without peritonitis were compared by Student’s t test.
*  p < 0 . 0 5
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during the short exchanges was similar in both groups (9.5 ± 1.7 ml 
in group 1 and 9.A ± 1.0 ml in group 2).
Fractional absorption rates (%) of glucose (M.W.=180), insulin 
(M.W.= 6,000) and albumin (M.W.= 68,000) from the dialysis solution 
during the exchanges are summarised in Table 20. Transperitoneal 
uptake of each solute was higher in the rats with peritonitis but 
only reached statistical significance for glucose (p < 0.05). Since
solutes of molecular weight greater than 20,000 are only absorbed 
from the peritoneal cavity by convective transport, the percentage 
absorption of albumin in each group will also indicate the percentage 
of glucose and insulin absorbed by bulk flow. Thus, in the rats with 
peritonitis, 34% of the dialysate glucose, insulin and albumin were 
absorbed by convection via the lymphatics, whereas 51% of the 
dialysate glucose, 15% of insulin and none of the albumin were 
absorbed by diffusion (Table 20). In the rats without peritonitis, 
26% of the dialysate glucose, insulin and albumin were absorbed by 
convective transport (Table 20).
8.4 DISCUSSION
In this study glucose and insulin were absorbed from the 
dialysis solution more rapidly during episodes of peritonitis in 
diabetic rats. However, the relative absorption rates of glucose and 
insulin and the hypoglycaemic response to absorbed insulin were not 
altered significantly by peritonitis. Thus, the same dosage of 
intraperitoneal insulin produced a comparable biological effect in
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TABLE 20: PERCENTAGE ABSORPTION OF DIALYSATE GLUCOSE, INSULIN
AND ALBUMIN DURING TWO HOUR EXCHANGES WITH 15 ML, 
2.5% DEXTROSE DIALYSIS SOLUTION IN DIABETIC RATS
ABSORPTION (%) GROUP 1 GROUP 2 *
Glucose 85 ± 8 47 ± 3 p < 0.05
Insulin 49 ± 5 44 ± 6
Albumin 34 ± 4 26 ± 3 p < 0.1
Mean ± SEM values were compared by Student's 
non-paired t test.
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both groups. These data suggest that intraperitoneal insulin 
therapy should not be increased routinely during peritonitis in 
diabetic CAPD patients unless extra hypertonic dextrose exchanges are 
required to achieve adequate daily net ultrafiltration.
Diabetes mellitus and peritonitis were induced successfully in 
the animal model described in this study. Furthermore, endogenous 
release of pro-insulin from residual pancreatic p-cells was excluded 
by demonstrating very low plasma C-peptide concentrations at the
beginning and end of the two hour exchanges (204). Thus, the rise in 
serum insulin (IRI) levels during the exchanges reflected 
transperitoneal absorption of insulin from the dialysis solution. 
Absorption kinetics of insulin from the peritoneal cavity cannot be 
evaluated quantitatively from peripheral blood insulin levels since 
50% of portal venous insulin is removed during first pass through the 
liver (205). The increments in serum IRI were greater during the 
second half of the exchanges in both groups of rats, even though the 
transperitoneal insulin concentration gradient for diffusive uptake 
into the peritoneal vasculature had decreased (p < 0.001) (Table 19, 
Figure 37). This apparent delay in insulin absorption may be 
explained by a lag phase before insulin transported via the
lymphatics reaches the systemic circulation (92,128,130,131).
Lymphatic absorption was higher during the exchanges in rats 
with peritonitis but the difference did not reach statistical
significance in the small number of animals studied. These results 
indicate that the functional patency of the peritoneal cavity
184
lymphatics is well maintained during episodes of peritonitis in this 
animal model.
Previous studies in rats have shown that macromolecules 
(M.W.> 20,000) are absorbed from the peritoneal cavity almost
exclusively by convective transport via the lymphatics (102,170). 
The fractional absorption rates of albumin and insulin in this study 
(Table 20) indicate that a significant proportion of peritoneal 
cavity to plasma transport of insulin is via convective transport. 
In rats with and without peritonitis, convection (via lymphatics) 
accounted for 69% and 59%, respectively of total insulin absorption 
from the dialysate. In a similar study in rats, absorption of inulin 
(M.W.= 5,200) from the dialysis solution was 81% translymphatic and 
only 19% by diffusion (170). These studies emphasise that lymphatic 
absorption is relatively more important in peritoneal cavity to 
plasma transport of molecules of increasing size and infer that 
diffusive uptake from the peritoneal cavity is through size 
discriminatory pores in the peritoneal capillaries and/or venules. 
(206)
The absorption of intraperitoneal insulin along with the 
obligatory dialysate glucose load is more physiological than 
subcutaneous insulin administration (207,208) and improves glycaemic 
control in diabetic CAPD patients (191,193,194). The addition of 
insulin to the infused dialysis solution avoids the need for 
subcutaneous injections and permits good patient compliance with 
administration of insulin four times per day. The intraperitoneal 
administration of insulin has no effect on solute clearances, net
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ultrafiltration or dialysate glucose absorption in CAPD patients 
(209) and has not been found to increase the risk of CAPD associated 
peritonitis (10,191,193). For these reasons, intraperitoneal insulin 
therapy is the route of choice for insulin administration in diabetic 
CAPD patients.
This study suggests that insulin requirements are unaltered 
during peritonitis in diabetic CAPD patients provided the dialysate 
glucose load and carbohydrate intake are kept constant.
8.5 CONCLUSIONS
1. Glucose and insulin are absorbed from the dialysate more rapidly 
during episodes of peritonitis in diabetic rats.
2. Greater than 50% of the absorption of intraperitoneal insulin 
during peritoneal dialysis is via the peritoneal cavity 
lymphatics.
3. Peritonitis per se does not change intraperitoneal insulin 
requirements during peritoneal dialysis in diabetic rats.
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Chapter 9: NEOSTIGMINE REDUCES LYMPHATIC ABSORPTION IN PERITONEAL
DIALYSIS IN THE RAT
9.1 INTRODUCTION
Pharmacological reduction of lymphatic absorption during the 
exchange time should augment net ultrafiltration and solute 
clearances in peritoneal dialysis. Most of the lymphatic drainage 
from the peritoneal cavity occurs N by convective flow via the 
subdiaphragmatic stomata (Figure 3). Intraperitoneal administration 
of cholinergic drugs has been observed to induce fixed contraction of 
these stomata (100) and consequently may decrease lymphatic 
absorption of intraperitoneal fluid. Neostigmine, an
anticholinesterase agent which is used therapeutically in myasthenia 
gravis, also ought to reduce the patency of the subdiaphragmatic 
stomata. This study was performed to evaluate if intraperitoneal 
neostigmine reduces lymphatic absorption and thus increases net 
ultrafiltration and solute clearances in peritoneal dialysis in rats.
9.2 MATERIALS AND METHODS
9.2.1 STUDY PROTOCOL
Two hour exchanges were performed in 19 ambulant, male Sprague- 
Dawley rats using 2.5% dextrose solution with and without added 
neostigmine. Albumin (25% human serum albumin) was added to 2.5%
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dextrose solution (Dianeal PD-2, Baxter-Travenol, Deerfield, 
Illinois) to give a 1.5% albumin solution. Under ether anaesthesia, 
20 ml of the 2.5% dextrose solution containing 1.5% albumin was 
infused through a 22 gauge needle into the peritoneal cavity of each 
rat. In ten of the rats 0.0063 mg/ml of neostigmine methylsulphate 
(Prostigmin, Roche Laboratories, Nutley, New Jersey) was also mixed 
with the instilled dialysis solution. This administered dosage 
corresponds with therapeutic dosages in adult man (210). The animals 
were then permitted to recover from anaesthesia and were ambulant 
and allowed water and rat chow ad libitum during the two hour dwell 
time. Ten minutes before the end of the exchange a peritoneal 
catheter was inserted in the midline under ether anaesthesia (5.2.1) 
and the dialysis solution drained completely.
Pre-dialysis blood was drawn from the tail vein and post­
dialysis blood was collected during sacrifice of the rats. The 
peritoneal cavity was opened to ensure complete drainage of the 
dialysate and the drain volume was measured in a graduated cylinder. 
Albumin, urea and creatinine concentrations and osmolality in the 
pre- and post-dialysis serum and dialysate samples were measured as 
described previously (6.2.3). Dialysate and serum phosphate were 
measured using the Autoanalyser II (Technicon Instruments 
Corporation, Tarrytown, New York).
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9*2.2 CALCULATIONS
Cumulative lymphatic absorption and net transcapillary 
ultrafiltration were calculated as before (6.2.A). Measured net 
ultrafiltration equalled the drain volume minus the infusion volume. 
Solute clearances of urea, creatinine and phosphate during the single 
peritoneal dialysis exchanges were calculated as the solute mass 
transfer rate (equation 1) divided by the mean serum solute 
concentration. Dialysate/serum solute ratios were determined at the 
end of the two hour exchanges to compare transperitoneal solute
transport with and without neostigmine added to the dialysis
solution. Results in each group of rats were compared by Student's
non-paired t test.
9.3 RESULTS
The dialysate drain volumes after the two hour dwell time were 
significantly higher in the neostigmine treated rats (23.7 ± 0.5
(SEM) ml) than in the control rats (21.5 ± O.A ml; p < 0.01). Thus, 
measured net ultrafiltration volumes were higher in the neostigmine 
treated group (p < 0.01 ) (Figure 38). Cumulative lymphatic
absorption and net transcapillary ultrafiltration at the end of the 
two hour exchanges in each group of rats are depicted in Figure 39. 
Although total net transcapillary ultrafiltration did not differ 
between the two groups, cumulative lymphatic absorption was decreased 
significantly during the exchanges with intraperitoneal neostigmine
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(p < 0.01) (Table 21, Figure 39). Calculated net ultrafiltration
(cumulative net transcapillary ultrafiltration minus lymphatic 
absorption) correlated with directly measured net ultrafiltration in 
both groups (r = 0.90).
Dialysate/serum ratios of urea, creatinine and phosphate after 
the two hour exchanges were not significantly different between the 
two groups of rats (Table 22). However, primarily due to the
increased drain volume, solute clearances were significantly greater 
in the neostigmine treated rats (Table 22).
Pre- and post-dialysis body weight, haematocrit and serum and 
dialysate osmolality were similar in both groups of rats (Table 23).
9.4 DISCUSSION
This study indicates that intraperitoneal neostigmine increases 
measured net ultrafiltration during peritoneal dialysis in rats by 
reducing cumulative lymphatic absorption, and without increasing 
total net transcapillary ultrafiltration during the exchange (Figure 
39). Solute clearances are enhanced by the resultant increase in the 
dialysate drain volume and not by a significant increase in 
transperitoneal solute transport. That is, both dialysate/serum
solute ratios and total net transcapillary ultrafiltration were 
unaltered by intraperitoneal neostigmine administration (Tables 21 & 
22). These data are consistent with the hypothesis that
intraperitoneal neostigmine impairs diaphragmatic lymphatic 
absorption and thus can augment the efficiency of peritoneal dialysis
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TABLE 21: INFLUENCE OF NEOSTIGMINE ON ULTRAFILTRATION KINETICS
AFTER TWO HOUR EXCHANGES USING 20 ML, 2.5% DEXTROSE 
DIALYSIS SOLUTION
RAT GROUP CONTROL NEOSTIGMINE
Net Transcapillary UF (ml) 8.16 ± 0.66 7.74 ± 0.72
Lymph Flow (ml) 5.58 ± 0.66 3.44 ± 0.51 P <
Calculated Net UF (ml) 2.58 ± 0.42 4.30 ± 0.48 P <
Measured Net UF (ml) 1.50 ± 0.44 3.70 ± 0.48 P <
* Mean ± SEM were compared by Student's t test.
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TABLE 22: EFFECT OF NEOSTIGMINE ON SOLUTE TRANSPORT AFTER
TWO HOUR EXCHANGES USING 20 ML, 2.5% DEXTROSE 
DIALYSIS SOLUTION
SOLUTE CLEARANCES (ml/min) CONTROL NEOSTIGMINE *
Urea 0.14 ± 0.03 0.16 ± 0.04 p < 0.01
Creatinine 0.09 ± 0.02 0.12 ± 0.05 p < 0.05
Phosphate 0.07 ± 0.01 0.08 ± 0.01 p < 0.05
DIALYSATE/SERUM SOLUTE RATIOS CONTROL NEOSTIGMINE
Urea 0.78 ± 0.08 0.81 ± 0.10
Creatinine 0.50 ± 0.10 0.60 ± 0.20
Phosphate 0.42 ± 0.10 0.42 ± 0.10
* Mean ± SD of solute clearances and dialysate/serum 
solute ratios in each group of rats were compared by Student's 
t test.
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without increasing transperitoneal transport of water and solutes 
into the peritoneal cavity.
The calculated lymphatic flow rates of the control rats in this 
study (Table 21) are in agreement with directly measured peritoneal 
lymphatic absorption rates of homologous plasma (Table 1) and 
confirm that lymphatic drainage significantly reduces measured net 
ultrafiltration during peritoneal dialysis in the rat (5.5). The 
close correlation of calculated and directly measured net 
ultrafiltration volumes further supports the validity of the methods. 
Linear regression analysis showed that calculated net ultrafiltration 
= (0.9 x measured net ultrafiltration) + 1.0 ml. This difference was 
most likely due to unmeasurable residual volumes, since the presence 
of clinically evident intraperitoneal fluid was excluded by opening 
the peritoneal cavity after drainage via the peritoneal catheter. 
The intraperitoneal residual volumes after immediate in and out 
exchanges in the rat model of peritoneal dialysis average 1.0 ml 
(5.3.1). Thus the increase in net ultrafiltration in the neostigmine 
treated rats cannot be attributed to differences in the completeness 
of drainage of intraperitoneal fluid.
The rats were awake and ambulant during the study exchanges 
since this model more closely simulates clinical peritoneal dialysis. 
This is especially important in studies of lymphatic absorption from 
the peritoneal cavity since the lymphatic flow rate is elevated by a 
rise in intraperitoneal pressure (112) and reduced by anaesthesia 
and decreased diaphragmatic movement (113,114). The intraperitoneal 
pressure was assumed to be similar in both groups of rats since the
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same volume of dialysis solution was infused in all rats and both 
groups of rats were of similar body weight (Table 23) (178). 
Furthermore, allowing the rats to recover from anaesthesia ensured 
that differences in the absorption of intraperitoneal fluid by the 
subdiaphragmic lymphatics were not caused by interindividual
variation in the depth of anaesthesia.
The subdiaphragmatic stomata constrict following intraperitoneal 
carbachol administration and relax when succinylcholine is infused 
(100). These observations may be explained by the presence of 
abundant actin filaments in the mesothelial and endothelial cells 
surrounding the stomata (99,100,211). Neostigmine also ought to 
constrict the stomata but this has yet to be confirmed by electron 
microscopy studies. The clinical use of neostigmine is hindered by 
the risk of muscarinic side effects and the danger of inducing 
cholinergic crisis in normal patients (210).
Lymphatic drainage from the peritoneal cavity may be amenable to 
pharmacological manipulation by other drugs. The lymphatic trunks
have both innervation by non-myelinated autonomic fibres and inherent 
contractility (212,213). Although denervation had no effect on 
spontaneous lymphatic contractility (213), inherent myogenicity was 
decreased .m vitro by calcium antagonists (214). Whether vasoactive 
drugs in vivo significantly alter lymphatic as well as blood vessel 
smooth muscle tone and contractility remains unknown. Drugs are 
delivered to the lymphatic trunks by the vasa lymphorum as well as in 
lymph (164) and thus oral or parenteral medication may potentially 
alter lymphatic flow. Review of the lymphatic absorption rates in
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CAPD patients (Chapter 6), however, revealed no influence of 
concurrent oral vasodilator therapy on lymphatic flow.
Pharmacological reduction of peritoneal lymphatic absorption 
provides an alternative means of enhancing the efficiency of long- 
dwell peritoneal dialysis without increasing peritoneal transport of 
water and solutes into the peritoneal cavity. Investigation of other 
drugs which may decrease lymphatic drainage is merited.
9.5 CONCLUSIONS
1. Intraperitoneal administration of neostigmine increases measured
net ultrafiltration and solute clearances in peritoneal dialysis
in the rat.
2. Net ultrafiltration and solute clearances are enhanced in the
neostigmine treated group by a reduction in peritoneal lymphatic
absorption, and without an increase in transperitoneal transport 
of water and solutes into the peritoneal cavity.
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Chapter 10. INFLUENCE OF PHOSPHATIDYLCHOLINE ON LYMPHATIC
ABSORPTION DURING PERITONEAL DIALYSIS IN THE RAT
10.1 INTRODUCTION
The layer of surface active phospholipids over serous membranes 
helps to provide mechanical lubrication for the underlying viscera 
and to repel water (215,216). Peritoneal physiology may be altered 
in CAPD by the constant removal of phosphatidylcholine and other 
phospholipids in the dialysate effluent (216). Phospholipid 
concentrations in dialysate effluent are significantly reduced after 
long-term CAPD and during episodes of peritonitis, and the poor 
peritoneal ultrafiltration capacity in such patients is greatly 
improved with intraperitoneal phosphatidylcholine administration 
(217). The observed increase in net ultrafiltration and solute 
clearances with phosphatidylcholine has been attributed to its 
surface tension lowering properties which result in a reduction in 
the thickness of the stagnant fluid films over the mesothelium and 
an increase in transperitoneal water and solute transport (217,218). 
Since glucose absorption from the dialysate did not increase during 
exchanges with phosphatidylcholine (217,218), this hypothesis assumes 
that the thinning of fluid films over the mesothelium only causes 
unidirectional enhancement of peritoneal transport from the
peritoneal vasculature to the dialysis solution (218).
Alternatively, phosphatidylcholine may increase the efficiency 
of peritoneal dialysis by reducing the reabsorption of water and
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solutes during the dwell time. Recent studies in rabbits suggest 
that phosphatidylcholine increases net ultrafiltration by reducing 
net fluid absorption late in the exchange (218). This study was 
performed to evaluate lymphatic absorption, ultrafiltration kinetics 
and solute transport during hypertonic exchanges with and without 
phosphatidylcholine in rats.
10.2 MATERIALS AND METHODS
10.2.1 STUDY PROTOCOL
Four hour exchanges with 20 ml of 4.25% dextrose dialysis 
solution were performed in four groups of ambulant, male Sprague- 
Dawley rats. The study dialysis solution in each group of six rats 
was as follows:
Group 1 = 4.25% dextrose + 1.5% albumin
Group 2 = 4.25% dextrose + 1.5% albumin + 50 mg/L phosphatidylcholine 
Group 3 = 4.25% dextrose
Group 4 = 4.25% dextrose + 50mg/L phosphatidylcholine
This dosage of phosphatidylcholine (50 mg/L) has been shown to 
increase net ultrafiltration during peritoneal dialysis in man and 
rabbits (217,218). Groups 1 and 3 served as control groups for the 
phosphatidylcholine treated rats with and without albumin (25% human 
serum albumin) added to the dialysis solution. Exchanges in groups
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3 and A were performed without albumin since it is anionic at 
physiological pH and may interfere with the mechanism of action of 
phosphatidylcholine (218).
Following ether anaesthesia, the abdominal area of the animals 
was shaved and scrubbed with 10% povidone-iodine solution for five 
minutes. The study dialysis solution was then injected
intraperitoneally using a 22 gauge needle. The rats were allowed to 
recover and permitted free access to water and rat chow throughout 
the dwell time. Ten minutes before the end of the four hour 
exchanges, the rats were again anaesthetised, a peritoneal catheter 
was inserted in the midline (5.2.1) and the dialysate drained 
completely.
Pre-dialysis blood was obtained from the tail vein and post­
dialysis blood was collected during sacrifice of the rats. The 
peritoneal cavity was then opened to ensure complete drainage of 
dialysate, and the drain volume was measured in a graduated cylinder.
10.2.2 LABORATORY METHODS AND CALCULATIONS
The osmolality and glucose, albumin, urea and phosphate 
concentrations of the pre- and post-dialysis serum and dialysate 
samples were measured as described previously (5.2.A and 9.2.1). 
Cumulative lymphatic absorption and net transcapillary 
ultrafiltration were calculated as before (5.2.5 and 6.2.A). 
Dialysate albumin concentrations at the end of the exchanges with 
1.5% added albumin were corrected for albumin influx during the dwell
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time by subtracting the mean dialysate albumin concentration of the 
corresponding rat group without albumin added to the dialysis 
solution. Net ultrafiltration was calculated as the drain volume 
minus the infusion volume. Solute clearances and dialysate/serum 
solute ratios were determined (9.2.2) to assess solute transport 
during the exchanges in each group of rats.
Results in groups 1 and 2 with albumin added to the dialysis 
solution and groups 3 and A without added albumin in the dialysate 
were compared by Student's non-paired t test.
10.3 RESULTS
The dialysate drain volumes were significantly higher during the 
exchanges with phosphatidylcholine. The drain volumes in group 1 
averaged 2A.2 ± 1.3 (SEM) ml compared with 30.8 ± 0.9 ml in group 2
(p < 0.005). In group 3 the drain volumes averaged 27.5 ± 1.2 ml
compared with 32.8 ± 0.3 ml in group A (p < 0.005). Consequently net 
ultrafiltration volumes were higher during the exchanges with 
phosphatidylcholine (groups 2 and A in Figures A0 and Al, 
respectively).
Cumulative lymphatic absorption after the four hour dwell time 
was reduced during exchanges with phosphatidylcholine (8.0 ± l.A ml 
in group 2 and 1A.3 ± 1.2 ml in group 1; p < 0.01). Cumulative net 
transcapillary ultrafiltration during the dwell time was calculated 
by adding measured net ultrafiltration and lymphatic absorption 
(5.2.5). The calculated net transcapillary ultrafiltration volumes
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Figure 40: Net ultrafiltration volumes after four hour exchanges
in rats using 20 ml of 1.5% albumin, 4.25% dextrose 
dialysis solution with (group 2) and without (group 1) 
added phosphatidylcholine. The mean of each group is 
indicated by the horizontal broken line.
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Figure 41: Net ultrafiltration volumes after four hour exchanges in
rats using 20 ml, 4.25% dextrose dialysis solution with 
(group 4) and without (group 3) addition of phosphatidyl­
choline.
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in group 1 (18.A ± 1.0 ml) were similar to group 2 (18.8 ± 1.2 ml). 
Estimation of cumulative net transcapillary ultrafiltration from the 
dilution of the initial dialysate albumin concentrations (6.2.A) 
showed similar results (20.0 ± l.A ml in group 1 and 17.5 ± 1.6 ml in 
group 2; N.S.). Thus the increase in net ultrafiltration during
exchanges with phosphatidylcholine is due to a reduction in lymphatic 
absorption during the dwell time rather than enhanced net
transcapillary ultrafiltration (Figure A2).
Peritoneal clearances of urea and phosphate were also increased 
during the exchanges with phosphatidylcholine (Table 2A). 
Dialysate/serum solute ratios after the four hour dwell time were 
similar in all groups of rats (Table 2A) and thus the augmented 
solute clearances in groups 2 and A are mainly due to the increased 
dialysate drain volume. Drain dialysate albumin concentrations did 
not differ significantly in groups 3 and A (0.11 ± 0.02 and 0.09 ±
0.01 g/dl, respectively), and further suggest that peritoneal 
permeability x area is unchanged by adding phosphatidylcholine to the 
dialysis solution.
Initial/drain dialysate glucose ratios were similar in each rat 
group (Table 2A). Nevertheless, due to the higher drain volumes, 
glucose absorption from the dialysate was lower after the exchanges 
with phosphatidylcholine (p < 0.01). The addition of albumin to the 
study dialysis solution, however, significantly lowered the initial 
dialysate glucose concentrations in groups 1 and 2 compared with 
groups 3 and A (p < 0.05) (Table 25). Consequently ultrafiltration 
kinetics and solute clearances in the first two groups of rats were
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SEM) after four hour exchanges in rats using 20 ml, 
A.25% dextrose dialysis solution with and without 
added phosphatidylcholine.
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TABLE 25; PRE- AND POST-DIALYSIS WEIGHT, HAEMATOCRIT AND SERUM AND 
DIALYSATE OSMOLALITY AND GLUCOSE CONCENTRATIONS
PRE-DIALYSIS DATA GROUP 1 GROUP 2 GROUP 3 GROUP 4
Weight (g)
Haematocrit (%)
Serum Osmolality (mOsm/L)) 
Dialysate Osmolality (mOsm/L) 
* Dialysate Glucose (mg/dl)
470 ± 27 
47 ± 2 
305 ± 5 
457 ± 5 
4482 ± 272
458 ± 22 
48 ± 2 
297 ± 5 
456 ± 8 
4466 ± 258
443 ± 22 
47 ± 2 
299 ± 8 
462 ± 5 
4751 ± 100
419 ± 23 
48 ± 2 
304 ± 10 
462 ± 5 
4751 ± 100
POST-DIALYSIS DATA GROUP 1 GROUP 2 GROUP 3 GROUP 4
Weight (g)
Haematocrit (%)
Serum Osmolality (mOsm/L) 
Dialysate Osmolality (mOsm/L) 
Dialysate Glucose (mg/dl)
464 ± 28 
48 ± 3 
307 ± 9 
288 ± 4 
672 ± 152
454 ± 20 
50 ± 1 
302 ± 6 
288 ± 4 
751 ± 53
437 ± 22 
50 ± 2 
310 ± 11 
282 ± 13 
862 ± 150
414 ± 22 
50 ± 2 
307 ± 10 
288 ± 8 
902 ± 44
* The initial dialysate glucose concentrations (mean ± SD) were 
lower in groups 1 and 2 due to dilution with added albumin (p < 0.05).
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not compared with groups 3 and 4. The drain dialysate was hyposmolar 
to post-dialysis serum in all of the rats (Table 25) and accords with 
prior observations during long-dwell exchanges in rats (Chapter 5). 
Body weight, haematocrit and serum osmolality were similar in each 
group of rats (Table 25).
10.4 DISCUSSION
This study confirms that the addition of phosphatidylcholine to 
the dialysis solution significantly increases net ultrafiltration and 
solute clearances in peritoneal dialysis (217,218). The enhanced 
efficiency of peritoneal dialysis with phosphatidylcholine has been 
postulated to result from a reduction in surface tension, a decrease 
in the thickness of stagnant fluid films over the mesothelium and a 
subsequent rise in transperitoneal transport of water and solutes 
into the peritoneal cavity (217). Chlorpromazine is presumed to
increase net ultrafiltration and solute clearances by a similar 
mechanism (219).
The data reported herein, however, indicate that net
ultrafiltration and drain volumes are increased during exchanges with
added phosphatidylcholine without a concurrent rise in total net
transcapillary ultrafiltration (Figure 42). Likewise, since drain 
dialysate/serum solute ratios were unchanged in exchanges with 
phosphatidylcholine, transperitoneal solute transport rates were not
increased and the enhanced solute clearances were related primarily 
to the rise in dialysate drain volume. Dialysate/serum solute ratios
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during exchanges with identical dialysis mechanics (dwell time, 
osmolality and volume of dialysis solution) are a useful index of 
peritoneal permeability x area (189). Thus, phosphatidylcholine 
increases net ultrafiltration and solute clearances during exchanges 
with the same dialysis mechanics without altering peritoneal 
permeability x area and without increasing transperitoneal transport 
of water and solutes from the peritoneal microcirculation.
Net ultrafiltration and solute clearances are augmented during 
exchanges with phosphatidylcholine due to a reduction in cumulative 
lymphatic absorption during the dwell time (Figure 42). This 
mechanism of action accords with earlier studies in rabbits which 
suggested that phosphatidylcholine reduced net fluid absorption late 
in the dwell time (218). Intraperitoneal volumes in the
phosphatidylcholine treated and control rabbits were similar after 
one and two hour dwell times, yet the drain volumes in the 
phosphatidylcholine exchanges were greater than twice control values 
after five hours. The similar intraperitoneal volumes in the first 
two hours and the unchanged rates of glucose absorption throughout 
the five hour dwell time suggest that both net transcapillary 
ultrafiltration early in the exchanges and the transperitoneal 
osmotic gradient during the exchanges are unaltered by the addition 
of phosphatidylcholine in rabbits (218). Short-dwell peritoneal 
exchanges with and without phosphatidylcholine would help to confirm 
these observations.
The site of action of phosphatidylcholine remains presumptive. 
The high density anionic charge on the lymphatic endothelium and, to
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a lesser extent, the microvilli and intercellular clefts of the 
subdiaphragmatic mesothelium may play a role in the resorption of 
intraperitoneal fluid into the interstitium or lymphatics (220). 
Positively charged choline may bind to and negate the surface anionic 
charge and thereby reduce the functional patency of the intercellular 
channels between mesothelial and lymphatic endothelial cells (221). 
This hypothesis is supported by the observation that the cationic 
dye, alcian blue, abolishes the effect of phosphatidylcholine in 
vitro (218). In this study, however, net ultrafiltration and solute 
clearances were still increased with phosphatidylcholine when anionic 
albumin was also added to the infused dialysis solution. 
Alternatively, the surface active properties of phosphatidylcholine 
may form a water repellent layer which limits fluid contact with the 
resorptive peritoneal surface.
Phosphatidylcholine is a normal constituent of dialysate 
effluent and fluid in the serous cavities (215-217). The prominence 
of intracellular synthetic organelles in the mesothelium from CAPD 
patients may reflect increased production of phosphatidylcholine in 
an attempt to compensate for constant losses in the dialysate 
(16,217). Phospholipid levels in the drain dialysate are decreased 
after long-term CAPD, especially in patients with poor 
ultrafiltration capacity and during episodes of peritonitis (217). 
The addition of 50 mg/L of phosphatidylcholine to the infused 
dialysis solution significantly improved ultrafiltration in a small 
series of such patients despite the likelihood of co-existing 
alterations in the integrity, and perhaps surface anionic charge, of
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the mesothelium (15-17). Further clinical studies are required to 
confirm these encouraging preliminary observations.
Reduction in peritoneal ultrafiltration capacity is not 
infrequent in CAPD patients (40-42) and has raised concerns regarding 
the long-term durability and viability of the peritoneum as a 
dialysing membrane when it is almost continuously exposed to non- 
physiological hypertonic dextrose dialysis solutions (222-224). 
Sustained net transcapillary ultrafiltration can be achieved with 
isosmolar glucose polymer dialysis solutions (225). However the 
clinical use of glucose polymer as an osmotic agent has so far been 
limited by its systemic absorption and subsequent accumulation of 
slowly metabolised and potentially toxic disaccharides.
Reduction of cumulative lymphatic absorption by 
phosphatidylcholine provides an alternative means of enhancing net 
ultrafiltration without increasing the osmolality of the dialysis 
solution. Phosphatidylcholine offers several potential advantages. 
Firstly, phosphatidylcholine is a normal component of peritoneal 
fluid and its addition to the dialysis solution may help restore and 
maintain normal peritoneal physiology. Secondly, by reducing 
intraperitoneal fluid absorption, phosphatidylcholine may decrease 
dialysate glucose absorption and allow a decrease in the osmolality 
of the dialysis solution. Thirdly, initial clinical studies indicate 
that phosphatidylcholine can greatly improve net ultrafiltration in 
patients with poor peritoneal ultrafiltration. Although injection of 
drugs into the infused dialysis solution may increase the risk of 
peritonitis, intraperitoneal administration of insulin in diabetic
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CAPD patients has not been found to increase the incidence of 
peritonitis (10).
Phosphatidylcholine may have considerable clinical benefits in 
long-dwell peritoneal dialysis, and merits more extensive clinical 
evaluation.
10.5 CONCLUSIONS
1. Phosphatidylcholine increases, net ultrafiltration and solute
clearances after four hour exchanges in rats.
2. Phosphatidylcholine increases the efficiency of long-dwell
peritoneal dialysis by reducing cumulative lymphatic absorption
and without increasing transperitoneal transport of water or 
solutes into the peritoneal cavity.
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